- en: <!--yml
  id: totrans-split-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-split-1
  prefs: []
  type: TYPE_NORMAL
  zh: 'category: 未分类'
- en: 'date: 2024-05-27 15:03:47'
  id: totrans-split-2
  prefs: []
  type: TYPE_NORMAL
  zh: 'date: 2024-05-27 15:03:47'
- en: -->
  id: totrans-split-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: 'Prevalence of sleep-disordered breathing in the general population: the HypnoLaus
    study - PMC'
  id: totrans-split-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 在一般人群中睡眠呼吸障碍的患病率：HypnoLaus研究 - PMC
- en: 来源：[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404207/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404207/)
  id: totrans-split-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404207/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404207/)
- en: Lancet Respir Med. Author manuscript; available in PMC 2015 Oct 1.
  id: totrans-split-6
  prefs: []
  type: TYPE_NORMAL
  zh: Lancet Respir Med. 作者手稿；PMC 2015年10月1日可用。
- en: '*Published in final edited form as:*'
  id: totrans-split-7
  prefs: []
  type: TYPE_NORMAL
  zh: '*最终编辑版本发表于：*'
- en: 'PMCID: PMC4404207'
  id: totrans-split-8
  prefs: []
  type: TYPE_NORMAL
  zh: PMCID：PMC4404207
- en: 'NIHMSID: NIHMS664840'
  id: totrans-split-9
  prefs: []
  type: TYPE_NORMAL
  zh: NIHMSID：NIHMS664840
- en: 'Prevalence of sleep-disordered breathing in the general population: the HypnoLaus
    study'
  id: totrans-split-10
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 一般人群中睡眠呼吸障碍的患病率：HypnoLaus研究
- en: '[R Heinzer](https://pubmed.ncbi.nlm.nih.gov/?term=Heinzer%20R%5BAuthor%5D)'
  id: totrans-split-11
  prefs: []
  type: TYPE_NORMAL
  zh: '[R Heinzer](https://pubmed.ncbi.nlm.nih.gov/?term=Heinzer%20R%5BAuthor%5D)'
- en: ','
  id: totrans-split-12
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[S Vat](https://pubmed.ncbi.nlm.nih.gov/?term=Vat%20S%5BAuthor%5D)'
  id: totrans-split-13
  prefs: []
  type: TYPE_NORMAL
  zh: '[S Vat](https://pubmed.ncbi.nlm.nih.gov/?term=Vat%20S%5BAuthor%5D)'
- en: ','
  id: totrans-split-14
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[P Marques-Vidal](https://pubmed.ncbi.nlm.nih.gov/?term=Marques-Vidal%20P%5BAuthor%5D)'
  id: totrans-split-15
  prefs: []
  type: TYPE_NORMAL
  zh: '[P Marques-Vidal](https://pubmed.ncbi.nlm.nih.gov/?term=Marques-Vidal%20P%5BAuthor%5D)'
- en: ','
  id: totrans-split-16
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[H Marti-Soler](https://pubmed.ncbi.nlm.nih.gov/?term=Marti-Soler%20H%5BAuthor%5D)'
  id: totrans-split-17
  prefs: []
  type: TYPE_NORMAL
  zh: '[H Marti-Soler](https://pubmed.ncbi.nlm.nih.gov/?term=Marti-Soler%20H%5BAuthor%5D)'
- en: ','
  id: totrans-split-18
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[D Andries](https://pubmed.ncbi.nlm.nih.gov/?term=Andries%20D%5BAuthor%5D)'
  id: totrans-split-19
  prefs: []
  type: TYPE_NORMAL
  zh: '[D Andries](https://pubmed.ncbi.nlm.nih.gov/?term=Andries%20D%5BAuthor%5D)'
- en: ','
  id: totrans-split-20
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[N Tobback](https://pubmed.ncbi.nlm.nih.gov/?term=Tobback%20N%5BAuthor%5D)'
  id: totrans-split-21
  prefs: []
  type: TYPE_NORMAL
  zh: '[N Tobback](https://pubmed.ncbi.nlm.nih.gov/?term=Tobback%20N%5BAuthor%5D)'
- en: ','
  id: totrans-split-22
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[V Mooser](https://pubmed.ncbi.nlm.nih.gov/?term=Mooser%20V%5BAuthor%5D)'
  id: totrans-split-23
  prefs: []
  type: TYPE_NORMAL
  zh: '[V Mooser](https://pubmed.ncbi.nlm.nih.gov/?term=Mooser%20V%5BAuthor%5D)'
- en: ','
  id: totrans-split-24
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[M Preisig](https://pubmed.ncbi.nlm.nih.gov/?term=Preisig%20M%5BAuthor%5D)'
  id: totrans-split-25
  prefs: []
  type: TYPE_NORMAL
  zh: '[M Preisig](https://pubmed.ncbi.nlm.nih.gov/?term=Preisig%20M%5BAuthor%5D)'
- en: ','
  id: totrans-split-26
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[A Malhotra](https://pubmed.ncbi.nlm.nih.gov/?term=Malhotra%20A%5BAuthor%5D)'
  id: totrans-split-27
  prefs: []
  type: TYPE_NORMAL
  zh: '[A Malhotra](https://pubmed.ncbi.nlm.nih.gov/?term=Malhotra%20A%5BAuthor%5D)'
- en: ','
  id: totrans-split-28
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[G Waeber](https://pubmed.ncbi.nlm.nih.gov/?term=Waeber%20G%5BAuthor%5D)'
  id: totrans-split-29
  prefs: []
  type: TYPE_NORMAL
  zh: '[G Waeber](https://pubmed.ncbi.nlm.nih.gov/?term=Waeber%20G%5BAuthor%5D)'
- en: ','
  id: totrans-split-30
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[P Vollenweider](https://pubmed.ncbi.nlm.nih.gov/?term=Vollenweider%20P%5BAuthor%5D)'
  id: totrans-split-31
  prefs: []
  type: TYPE_NORMAL
  zh: '[P Vollenweider](https://pubmed.ncbi.nlm.nih.gov/?term=Vollenweider%20P%5BAuthor%5D)'
- en: ','
  id: totrans-split-32
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: '[M Tafti](https://pubmed.ncbi.nlm.nih.gov/?term=Tafti%20M%5BAuthor%5D)'
  id: totrans-split-33
  prefs: []
  type: TYPE_NORMAL
  zh: '[M Tafti](https://pubmed.ncbi.nlm.nih.gov/?term=Tafti%20M%5BAuthor%5D)'
- en: ','
  id: totrans-split-34
  prefs: []
  type: TYPE_NORMAL
  zh: ','
- en: ^*
  id: totrans-split-35
  prefs: []
  type: TYPE_NORMAL
  zh: ^*
- en: and
  id: totrans-split-36
  prefs: []
  type: TYPE_NORMAL
  zh: and
- en: '[J Haba-Rubio](https://pubmed.ncbi.nlm.nih.gov/?term=Haba-Rubio%20J%5BAuthor%5D)^*'
  id: totrans-split-37
  prefs: []
  type: TYPE_NORMAL
  zh: '[J Haba-Rubio](https://pubmed.ncbi.nlm.nih.gov/?term=Haba-Rubio%20J%5BAuthor%5D)^*'
- en: '**Center for Investigation and Research in Sleep** (R Heinzer MD, S Vat MD,
    D Andries RPSGT, N Tobback RPSGT, M Tafti PhD, J Haba-Rubio MD), **Pulmonary Department**
    (R Heinzer), **Department of Internal Medicine** (P Marques-Vidal MD, G Waeber
    MD, P Vollenweider MD), **Laboratory Department** (V Mooser MD), **and Psychiatry
    Department** (M Preisig MD), **University Hospital of Lausanne, Lausanne, Switzerland;
    Pulmonary Medicine Department, University Hospital of Montreal, Montreal, QC,
    Canada** (S Vat); **Institute of Social and Preventive Medicine** (H Marti-Soler
    PhD) **and Center for Integrative Genomics** (M Tafti), **University of Lausanne,
    Lausanne, Switzerland; and University of Southern California San Diego, Division
    of Pulmonary and Critical Care, La Jolla, CA, USA** (A Malhotra MD)'
  id: totrans-split-38
  prefs: []
  type: TYPE_NORMAL
  zh: '**睡眠调查和研究中心** (R Heinzer MD, S Vat MD, D Andries RPSGT, N Tobback RPSGT, M
    Tafti PhD, J Haba-Rubio MD)，**肺部科** (R Heinzer)，**内科** (P Marques-Vidal MD, G
    Waeber MD, P Vollenweider MD)，**实验室科** (V Mooser MD)，**精神科** (M Preisig MD)，**洛桑大学医院，瑞士洛桑**；**蒙特利尔大学医院肺部医学科，加拿大蒙特利尔**
    (S Vat)；**社会与预防医学研究所** (H Marti-Soler PhD) **和综合基因组中心** (M Tafti)，**洛桑大学，瑞士洛桑**；**南加州大学圣地亚哥分校，肺部与重症护理科**
    (A Malhotra MD)'
- en: 'Correspondence to: Dr Raphael Heinzer, Center for Investigation and Research
    in Sleep and Pulmonary, Department, Lausanne, University Hospital of Lausanne,
    Lausanne University, 1011 Lausanne, Switzerland,'
  id: totrans-split-39
  prefs: []
  type: TYPE_NORMAL
  zh: 通讯地址：瑞士洛桑大学洛桑大学医院睡眠和肺部研究中心，Raphael Heinzer博士，
- en: '[hc.vuhc@reznieh.leahpar](mailto:dev@null)'
  id: totrans-split-40
  prefs: []
  type: TYPE_NORMAL
  zh: '[hc.vuhc@reznieh.leahpar](mailto:dev@null)'
- en: ^*Joint last authors
  id: totrans-split-41
  prefs: []
  type: TYPE_NORMAL
  zh: ^*共同通讯作者
- en: The publisher's final edited version of this article is available at
  id: totrans-split-42
  prefs: []
  type: TYPE_NORMAL
  zh: 本文的最终编辑版本可在以下处获得
- en: '[Lancet Respir Med](/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25682233)'
  id: totrans-split-43
  prefs: []
  type: TYPE_NORMAL
  zh: '[Lancet Respir Med](/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25682233)'
- en: Summary
  id: totrans-split-44
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 摘要
- en: Background
  id: totrans-split-45
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 背景
- en: Sleep-disordered breathing is associated with major morbidity and mortality.
    However, its prevalence has mainly been selectively studied in populations at
    risk for sleep-disordered breathing or cardiovascular diseases. Taking into account
    improvements in recording techniques and new criteria used to define respiratory
    events, we aimed to assess the prevalence of sleep-disordered breathing and associated
    clinical features in a large population-based sample.
  id: totrans-split-46
  prefs: []
  type: TYPE_NORMAL
  zh: 睡眠呼吸障碍与主要的发病率和死亡率相关。然而，其患病率主要是在存在睡眠呼吸障碍或心血管疾病风险的人群中有选择性地进行研究。考虑到记录技术的改进和新的定义呼吸事件标准的使用，我们旨在评估睡眠呼吸障碍的患病率及其相关的临床特征，这是一个大规模的基于人群的样本。
- en: Methods
  id: totrans-split-47
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 方法
- en: Between Sept 1, 2009, and June 30, 2013, we did a population-based study (HypnoLaus)
    in Lausanne, Switzerland. We invited a cohort of 3043 consecutive participants
    of the CoLaus/PsyCoLaus study to take part. Polysomnography data from 2121 people
    were included in the final analysis. 1024 (48%) participants were men, with a
    median age of 57 years (IQR 49–68, range 40–85) and mean body-mass index (BMI)
    of 25·6 kg/m² (SD 4·1). Participants underwent complete polysomnographic recordings
    at home and had extensive phenotyping for diabetes, hypertension, metabolic syndrome,
    and depression. The primary outcome was prevalence of sleep-disordered breathing,
    assessed by the apnoea-hypopnoea index.
  id: totrans-split-48
  prefs: []
  type: TYPE_NORMAL
  zh: 在2009年9月1日至2013年6月30日期间，我们在瑞士洛桑进行了一项基于人群的研究（HypnoLaus）。我们邀请了CoLaus/PsyCoLaus研究中连续3043名参与者组成的队列参与研究。最终分析包括了2121人的多导睡眠图数据。1024名（48%）参与者为男性，年龄中位数为57岁（IQR
    49–68，范围40–85岁），平均体重指数（BMI）为25·6 kg/m²（标准差4·1）。参与者在家中进行完整的多导睡眠图记录，并进行了糖尿病、高血压、代谢综合征和抑郁症的广泛表型分型。主要结果是通过呼吸暂停低通气指数评估的睡眠呼吸障碍的患病率。
- en: Findings
  id: totrans-split-49
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 发现
- en: The median apnoea-hypopnoea index was 6·9 events per h (IQR 2·7–14·1) in women
    and 14·9 per h (7·2–27·1) in men. The prevalence of moderate-to-severe sleep-disordered
    breathing (≥15 events per h) was 23·4% (95% CI 20·9–26·0) in women and 49·7% (46·6–52·8)
    in men. After multivariable adjustment, the upper quartile for the apnoea-hypopnoea
    index (>20·6 events per h) was associated independently with the presence of hypertension
    (odds ratio 1·60, 95% CI 1·14–2·26; p=0·0292 for trend across severity quartiles),
    diabetes (2·00, 1·05–3·99; p=0·0467), metabolic syndrome (2·80, 1·86–4·29; p<0·0001),
    and depression (1·92, 1·01–3·64; p=0·0292).
  id: totrans-split-50
  prefs: []
  type: TYPE_NORMAL
  zh: 女性的中位数呼吸暂停低通气指数为每小时6·9次（IQR 2·7–14·1），男性为每小时14·9次（7·2–27·1）。中重度睡眠呼吸障碍（每小时≥15次事件）的患病率为女性23·4%（95%
    CI 20·9–26·0），男性49·7%（46·6–52·8）。在多变量调整后，呼吸暂停低通气指数的最高四分位数（>20·6次每小时）与高血压（比值比1·60，95%
    CI 1·14–2·26；p=0·0292，趋势调整）、糖尿病（2·00，1·05–3·99；p=0·0467）、代谢综合征（2·80，1·86–4·29；p<0·0001）和抑郁症（1·92，1·01–3·64；p=0·0292）的独立相关性显著。
- en: Interpretation
  id: totrans-split-51
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 解释
- en: The high prevalence of sleep-disordered breathing recorded in our population-based
    sample might be attributable to the increased sensitivity of current recording
    techniques and scoring criteria. These results suggest that sleep-disordered breathing
    is highly prevalent, with important public health outcomes, and that the definition
    of the disorder should be revised.
  id: totrans-split-52
  prefs: []
  type: TYPE_NORMAL
  zh: 我们基于人群的样本中记录到的高患有睡眠呼吸障碍的患病率可能归因于当前记录技术和评分标准的增强敏感性。这些结果表明，睡眠呼吸障碍的患病率很高，具有重要的公共健康结果，睡眠呼吸障碍的定义应进行修订。
- en: Funding
  id: totrans-split-53
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 资金支持
- en: Faculty of Biology and Medicine of Lausanne, Lausanne University Hospital, Swiss
    National Science Foundation, Leenaards Foundation, GlaxoSmithKline, Ligue Pulmonaire
    Vaudoise.
  id: totrans-split-54
  prefs: []
  type: TYPE_NORMAL
  zh: 洛桑大学医院生物与医学系、瑞士国家科学基金会、Leenaards基金会、葛兰素史克公司、Vaud肺联盟。
- en: Introduction
  id: totrans-split-55
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 简介
- en: 'Sleep-disordered breathing is a chronic disorder caused by repeated upper-airway
    collapse during sleep, resulting in recurrent nocturnal asphyxia, fragmented sleep,
    major fluctuations in blood pressure, and increased sympathetic nervous system
    activity.^([1](#R1)) Furthermore, patients with untreated sleep-disordered breathing
    are at increased risk of hypertension, stroke, heart failure, diabetes, car accidents,
    and depression.^([2](#R2)–[9](#R9)) Polysomnography is the gold standard to diagnose
    sleep-disordered breathing. However, despite the important effect of sleep-disordered
    breathing on public health, only a few attempts have been made to screen the general
    population for this disorder using polysomnography. In the late 1980s and early
    1990s, three large cohort studies were done in the USA: the Wisconsin Sleep Cohort
    Study,^([10](#R10)) the Sleep Heart Health Study,^([11](#R11)) and the Penn State
    Cohort.^([12](#R12)) From these studies, the prevalence of sleep-disordered breathing—defined
    by an apnoea-hypopnoea index greater than five events per h—was estimated to be
    between 6·5% and 9% in women and between 17% and 31% in men.^([10](#R10),[12](#R12))
    However, this prevalence has since been revised to around 34% in men aged 30–70
    years and 17% in women aged 30–70 years.^([13](#R13)) Although these studies provide
    important epidemiological data, they included an enriched selection of people
    at risk for sleep-disordered breathing (based on questionnaires) or cardiovascular
    disease. Therefore, the prevalence of sleep-disordered breathing could not be
    measured directly but was estimated through complex statistical calculations with
    reference to other population-based studies.'
  id: totrans-split-56
  prefs: []
  type: TYPE_NORMAL
  zh: 睡眠呼吸紊乱是一种慢性疾病，由于睡眠期间上呼吸道重复性塌陷导致夜间反复窒息、睡眠碎片化、血压波动显著增加和交感神经系统活性增强所致。^([1](#R1))
    此外，未经治疗的睡眠呼吸紊乱患者面临高血压、中风、心力衰竭、糖尿病、车祸和抑郁的风险增加。^([2](#R2)–[9](#R9)) 多导睡眠图检查是诊断睡眠呼吸紊乱的金标准。然而，尽管睡眠呼吸紊乱对公共健康的重要影响，只有少数尝试使用多导睡眠图对一般人群进行筛查。在1980年代末和1990年代初，美国进行了三项大型队列研究：威斯康星睡眠队列研究，^([10](#R10))
    睡眠心脏健康研究，^([11](#R11)) 和宾夕法尼亚州队列研究。^([12](#R12)) 从这些研究中，根据每小时呼吸暂停-低通气指数大于五次定义的睡眠呼吸紊乱的患病率在女性中估计为6.5%至9%，在男性中为17%至31%。^([10](#R10),[12](#R12))
    然而，这一患病率已被修订为男性30至70岁约为34%，女性30至70岁约为17%。^([13](#R13)) 尽管这些研究提供了重要的流行病学数据，但它们包括了通过问卷选择风险较高的人群或心血管疾病患者。因此，睡眠呼吸紊乱的患病率无法直接测量，而是通过复杂的统计计算估计，参照其他基于人群的研究。
- en: Researchers on subsequent epidemiological studies have either selected specific
    ethnic groups^([14](#R14),[15](#R15)) or high-risk populations.^([16](#R16)) To
    record nocturnal breathing, all except a few^([13](#R13),[17](#R17)) used less
    sensitive technology (eg, pen and paper recorders, thermocouples, or respiratory
    inductive plethysmography)^([16](#R16),[18](#R18)) than nasal pressure technology,
    which is now the standard of care. Furthermore, pulse oximeters have improved
    considerably over the years. Both technical developments have increased sensitivity
    for diagnosis of sleep-disordered breathing. Moreover, the American Academy of
    Sleep Medicine (AASM) has revised criteria used to define nocturnal respiratory
    events.^([19](#R19)–[21](#R21)) Because most clinical settings now use recording
    techniques with increased sensitivity and the new definitions for respiratory
    events, the prevalence of sleep-disordered breathing and its association with
    important health outcomes needs to be revisited.
  id: totrans-split-57
  prefs: []
  type: TYPE_NORMAL
  zh: 随后的流行病学研究研究人员选择了特定的种族群体^([14](#R14),[15](#R15)) 或高风险人群。^([16](#R16)) 为了记录夜间呼吸，除少数例外^([13](#R13),[17](#R17))
    外，大多数研究采用了比鼻压技术（现在的标准护理）更不敏感的技术（如笔和纸记录仪、热电偶或呼吸感应容积描记术）。^([16](#R16),[18](#R18))
    此外，脉搏血氧仪在这些年来有了显著改进。这两项技术发展提高了睡眠呼吸紊乱的诊断敏感性。此外，美国睡眠医学学会（AASM）已经修订了定义夜间呼吸事件的标准。^([19](#R19)–[21](#R21))
    由于大多数临床设置现在使用了提高敏感性的记录技术和新的呼吸事件定义，需要重新审视睡眠呼吸紊乱的患病率及其与重要健康结果的关联。
- en: We designed the HypnoLaus Sleep Cohort study to assess the prevalence of sleep-disordered
    breathing using state-of-the-art polysomnographic recording techniques and updated
    definitions in a general unselected population. Furthermore, the clinical relevance
    of the revised definition of sleep-disordered breathing was also investigated
    by examining its associations with cardiovascular, metabolic, and psychiatric
    comorbidities.
  id: totrans-split-58
  prefs: []
  type: TYPE_NORMAL
  zh: 我们设计了HypnoLaus睡眠队列研究，使用先进的多导睡眠图记录技术和更新的定义，评估一般非选定人群中睡眠呼吸障碍的患病率。此外，通过研究修订后的睡眠呼吸障碍定义与心血管、代谢和精神共病的关联，还探讨了其临床相关性。
- en: Methods
  id: totrans-split-59
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 方法
- en: Participants
  id: totrans-split-60
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 参与者
- en: We selected participants for our study from individuals included in the population-based
    CoLaus/PsyCoLaus cohort study, described previously.^([22](#R22),[23](#R23)) Briefly,
    the CoLaus/PsyCoLaus study was undertaken between 2003 and 2006 and included a
    sample of 6733 people aged 35–75 years, who were selected at random (using Stata
    version 9.1) from the population register of the city of Lausanne, Switzerland
    (altitude approximately 490 m).^([22](#R22)) The distribution of age groups, sex,
    and postal codes in CoLaus/PsyCoLaus participants was representative of the source
    population.^([22](#R22)) The original aim of the CoLaus/PsyCoLaus cohort study
    was to investigate the prevalence of cardiovascular risk factors and psychiatric
    disorders in the general population and to identify genetic determinants and mechanisms
    involved in their association.
  id: totrans-split-61
  prefs: []
  type: TYPE_NORMAL
  zh: 我们从已描述的人群基础CoLaus/PsyCoLaus队列研究中选择了我们研究的参与者。简要地说，CoLaus/PsyCoLaus研究是在2003年至2006年间进行的，包括一份来自瑞士洛桑市（海拔约490米）人口登记处随机选择的35-75岁的6733人样本（使用Stata版本9.1）。CoLaus/PsyCoLaus参与者的年龄组、性别和邮政编码分布代表了源人群。^([22](#R22))
    CoLaus/PsyCoLaus队列研究的最初目的是调查一般人群中心血管危险因素和精神障碍的患病率，以及确定与其关联的遗传决定因素和机制。
- en: At 5-year follow-up of the CoLaus/PsyCoLaus cohort (in 2009–12), individuals
    who were willing to return underwent a second physical (n=5064) and psychiatric
    (n=4001) examination and were given questionnaires by trained interviewers. These
    assessments included questions on their demographic, medical, and treatment history,
    and smoking and alcohol consumption. Sleep-related complaints and habits were
    investigated using the Pittsburgh sleep quality index, the Epworth sleepiness
    scale, and the Berlin questionnaire for sleep-disordered breathing. Blood samples
    were taken in the fasting state and a large panel of biological variables was
    measured.^([24](#R24)) Selection of participants for the HypnoLaus Sleep Cohort
    study was consecutive and not based on responses to the questionnaires; investigators
    were unaware of the results of the questionnaires.
  id: totrans-split-62
  prefs: []
  type: TYPE_NORMAL
  zh: 在CoLaus/PsyCoLaus队列的5年随访（2009-12年），愿意返回的个体进行了第二次身体（n=5064）和精神（n=4001）检查，并由训练有素的访谈者进行问卷调查。这些评估包括他们的人口统计学、医疗和治疗历史、吸烟和饮酒情况。使用匹兹堡睡眠质量指数、Epworth嗜睡量表和柏林睡眠呼吸问卷调查了与睡眠相关的投诉和习惯。在空腹状态下采集血样，并测量了大量生物学变量。^([24](#R24))
    HypnoLaus睡眠队列研究参与者的选择是连续的，不基于问卷的回答；研究者对问卷结果不知情。
- en: The ethics committee of the University of Lausanne approved the CoLaus/PsyCoLaus
    cohort study and the HypnoLaus Sleep Cohort study. We obtained written informed
    consent from all participants.
  id: totrans-split-63
  prefs: []
  type: TYPE_NORMAL
  zh: 洛桑大学伦理委员会批准了CoLaus/PsyCoLaus队列研究和HypnoLaus睡眠队列研究。我们获得了所有参与者的书面知情同意。
- en: Procedures
  id: totrans-split-64
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 过程
- en: Polysomnography was done by certified technicians to assess the prevalence of
    sleep-disordered breathing. They equipped participants with a polysomnographic
    recorder (Titanium, Embla Flaga, Reykjavik, Iceland) between 1700 h and 2000 h
    at the Center for Investigation and Research in Sleep at the University Hospital
    of Lausanne. All sleep recordings took place in the patients’ home environment
    in accordance with 2007 AASM recommended setup specifications.^([19](#R19)) We
    recorded breathing using nasal pressure sensors. We asked individuals who were
    currently receiving treatment for sleep-disordered breathing (n=38) to discontinue
    their treatment 1 week before the sleep recording.
  id: totrans-split-65
  prefs: []
  type: TYPE_NORMAL
  zh: 多导睡眠图由认证技术人员进行，以评估睡眠呼吸障碍的流行率。他们在洛桑大学医院睡眠调查与研究中心在1700至2000点之间为参与者配备多导睡眠图记录仪（Titanium，Embla
    Flaga，冰岛雷克雅未克）。所有睡眠记录均在患者家庭环境中进行，符合2007年AASM推荐的设置规范。^([19](#R19)) 我们使用鼻压传感器记录呼吸。我们要求目前接受睡眠呼吸障碍治疗的个体（n=38）在睡眠记录前停止治疗一周。
- en: Two trained sleep technicians (DA and NT) who were unaware of the results of
    the previous questionnaires scored polysomnographic recordings manually using
    Somnologica software (version 5.1.1, Embla Flaga, Reykjavik, Iceland). An expert
    sleep clinician (JH-R) reviewed every recording and a second sleep expert (RH)
    did random quality checks. Quality control for concordance between the two polysomnography
    scorers was implemented periodically to ensure that both technicians achieved
    at least 90% agreement for sleep stages and respiratory events and an 85% level
    of agreement for arousals.^([25](#R25)) We scored sleep stages and arousals according
    to 2007 AASM recommendations.^([19](#R19)) We defined apnoea as a drop of at least
    90% of airflow from baseline lasting 10 s or longer. We initially scored hypopnoea
    events using 1999 AASM Chicago criteria,^([20](#R20)) but all recordings were
    rescored using the more restrictive 2007 AASM criteria^([19](#R19)) and the more
    liberal 2012 AASM criteria^([21](#R21)) (≥30% drop of airflow lasting at least
    10 s with either an arousal or ≥3% oxygen saturation drop). We used the 2012 criteria
    for our analysis (because they are the most recent and currently recommended criteria)
    and reported the average number of apnoea and hypopnoea events per h of sleep
    (the apnoea-hypopnoea index). We defined sleep-disordered breathing with usual
    clinical thresholds (ie, no sleep-disordered breathing, <5 events per h; mild,
    ≥5 to <15 events per h; moderate, ≥15 to <30 events per h; and severe, ≥30 events
    per h). The [appendix (p 4)](#FN2) shows apnoea-hypopnoea index scores using 1999
    and 2007 criteria.^([19](#R19),[20](#R20)) We defined excessive daytime sleepiness
    as an Epworth score greater than ten (maximum score 24).
  id: totrans-split-66
  prefs: []
  type: TYPE_NORMAL
  zh: 两名接受过训练的睡眠技术人员（DA 和 NT），他们不知道以前问卷的结果，使用Somnologica软件（版本5.1.1，Embla Flaga，冰岛雷克雅未克）手动评分多导睡眠图记录。睡眠专家（JH-R）审查了每一次记录，第二位睡眠专家（RH）进行了随机质量检查。定期实施双多导睡眠图评分员之间的一致性质量控制，以确保两名技术人员对睡眠阶段和呼吸事件达成至少90%的一致性以及85%的唤醒一致性。^([25](#R25))
    我们根据2007年AASM建议对睡眠阶段和唤醒进行评分。^([19](#R19)) 我们定义呼吸暂停为基线气流至少下降90%并持续10秒或更长时间。我们最初使用1999年AASM芝加哥标准对低通气事件进行评分，^([20](#R20))
    但所有记录都重新使用更严格的2007年AASM标准^([19](#R19)) 和更宽松的2012年AASM标准^([21](#R21))（气流下降≥30%，持续至少10秒，伴有唤醒或≥3%的氧饱和度下降）。我们在分析中使用了2012年的标准（因为它们是最新和当前推荐的标准），并报告了每小时睡眠的平均呼吸暂停和低通气事件数（呼吸暂停-低通气指数）。我们根据通常的临床阈值定义睡眠呼吸障碍（即没有睡眠呼吸障碍，<5事件/小时；轻度，≥5到<15事件/小时；中度，≥15到<30事件/小时；重度，≥30事件/小时）。[附录（第4页）](#FN2)显示使用1999年和2007年标准的呼吸暂停-低通气指数评分。^([19](#R19),[20](#R20))
    我们将过度白天嗜睡定义为Epworth分数大于十（最高分24分）。
- en: We did various clinical tests before polysomnography to investigate the association
    of sleep-disordered breathing with cardiovascular, metabolic, and psychiatric
    comorbidities. We measured blood pressure three times on the left arm and calculated
    the average of the last two readings. We defined arterial hypertension as either
    systolic blood pressure of 140 mm Hg or higher, diastolic blood pressure of 90
    mm Hg or higher, or current use of antihypertensive drugs. We calculated the waist-to-hip
    ratio as the ratio of the circumference of the waist to that of the hip, as recommended
    by WHO. We measured neck circumference between the mid-cervical spine and the
    mid-anterior neck, just below the laryngeal prominence, if palpable. We obtained
    a fasting blood sample for various analyses, including measurement of glucose
    concentration and lipids. We defined diabetes as either fasting blood glucose
    of 7 mmol/L or higher or current drug treatment for diabetes. We defined metabolic
    syndrome according to the Adult Treatment Panel III (ATP-III) report.^([26](#R26))
    Participants self-reported their alcohol drinking habits and the number of alcoholic
    drinks taken during the evening preceding the polysomnographic recording. We used
    the semi-structured Diagnostic Interview for Genetic Studies to diagnose a current
    major depressive episode, which we defined according to criteria of the Diagnostic
    and Statistical Manual of Mental Disorders, 4th edition (DSM-IV).
  id: totrans-split-67
  prefs: []
  type: TYPE_NORMAL
  zh: '我们在多导睡眠图记录之前进行了各种临床测试，以调查睡眠呼吸障碍与心血管、代谢和精神共病的关联。我们在左臂上测量了三次血压，并计算了最后两次测量的平均值。我们将动脉高压定义为收缩压达到或超过140
    mm Hg、舒张压达到或超过90 mm Hg，或当前使用抗高血压药物。我们按照世界卫生组织的建议，计算了腰臀比，即腰围与臀围的比值。我们在中颈椎和前颈中部之间，即在喉结下可触及处，测量了颈围。我们获取了空腹血样进行各种分析，包括测量血糖浓度和血脂。我们将糖尿病定义为空腹血糖达到或超过7
    mmol/L，或当前接受糖尿病药物治疗。我们根据《成人治疗第三报告》（ATP-III）定义代谢综合征。^([26](#R26)) 参与者自报了他们的饮酒习惯，以及在多导睡眠图记录之前晚上饮酒的数量。我们使用半结构化的遗传研究诊断访谈，根据《精神障碍诊断与统计手册第四版》（DSM-IV）的标准，诊断当前的重性抑郁发作。  '
- en: Statistical analysis
  id: totrans-split-68
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 统计分析
- en: We did all statistical analyses with Stata version 11 (College Station, TX,
    USA) and R. We summarised data as either the number of participants (% or 95%
    CI), mean (SD), and median (IQR). We did bivariate analyses with the χ² test,
    Student’s *t* test, or Wilcoxon’s rank-sum test. We used Cohen’s *d* to calculate
    the effect size of the differences between participants who underwent polysomnography
    and those who did not. We used logistic regression models to assess the association
    between various demographic and clinical variables and both mild-to-severe sleep-disordered
    breathing (≥5 events per h on the apnoea-hypopnoea index) and moderate-to-severe
    sleep-disordered breathing (≥15 per h on the apnoea-hypopnoea index), in men and
    women. To estimate the association between severity of sleep-disordered breathing
    and risk of diabetes, hypertension, metabolic syndrome, and depression, we used
    logistic regression models and divided our sample into quartiles of apnoea-hypopnoea
    index (Q1, 0–4·2 events per h; Q2, 4·3–9·9 events per h; Q3, 10·0–20·6 per h;
    Q4, >20·6 events per h). We compared models with the likelihood ratio test.
  id: totrans-split-69
  prefs: []
  type: TYPE_NORMAL
  zh: '我们使用 Stata 11 版本（美国德克萨斯州科利奇站）和 R 进行了所有统计分析。我们将数据总结为参与者的数量（% 或 95% CI）、均值（SD）和中位数（IQR）。我们使用
    χ² 检验、Student''s *t* 检验或 Wilcoxon 秩和检验进行双变量分析。我们使用 Cohen''s *d* 计算进行多导睡眠图检查和未进行多导睡眠图检查的参与者之间差异的效应大小。我们使用
    logistic 回归模型评估不同人口统计学和临床变量与男性和女性中轻度至重度睡眠呼吸障碍（每小时≥5次的阻塞-低通气指数）和中度至重度睡眠呼吸障碍（每小时≥15次的阻塞-低通气指数）之间的关联。为了估计睡眠呼吸障碍严重程度与糖尿病、高血压、代谢综合征和抑郁风险之间的关联，我们使用
    logistic 回归模型，并将样本分为阻塞-低通气指数的四分位数（Q1，0–4·2次/小时；Q2，4·3–9·9次/小时；Q3，10·0–20·6次/小时；Q4，>20·6次/小时）。我们使用似然比检验比较模型。  '
- en: Role of the funding sources
  id: totrans-split-70
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: '资金来源的角色  '
- en: The Faculty of Biology and Medicine of Lausanne, the Lausanne University Hospital
    (CHUV), Leenaards Foundation, and Ligue Pulmonaire Vaudoise funded the salary
    of the technicians who did the sleep recordings. The Swiss National Science Foundation
    funded the statisticians and supported the initial CoLaus cohort. GlaxoSmithKline
    supported the initial CoLaus cohort and funded the polysomnography recorders.
    The funders of the study had no role in study design, data collection, data analysis,
    data interpretation, or writing of the report. The corresponding author had full
    access to all data in the study and had final responsibility for the decision
    to submit for publication.
  id: totrans-split-71
  prefs: []
  type: TYPE_NORMAL
  zh: 洛桑大学生物与医学院，洛桑大学医院（CHUV），Leenaards基金会和Ligue Pulmonaire Vaudoise资助了进行睡眠记录的技术人员的工资。瑞士国家科学基金会资助了统计学家，并支持最初的CoLaus队列。GlaxoSmithKline支持了最初的CoLaus队列，并资助了多导睡眠记录仪。研究资助者在研究设计、数据收集、数据分析、数据解释或报告撰写中没有任何作用。通讯作者完全访问了研究中的所有数据，并最终决定提交出版。
- en: Results
  id: totrans-split-72
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 结果
- en: Between Sept 1, 2009, and June 30, 2013, a consecutive sample of 3043 people
    from the CoLaus/PsyCoLaus study cohort were invited to undergo polysomnography
    overnight at their home ([appendix p 1](#FN2)). Of these, 2168 (71%) individuals
    accepted the invitation and underwent polysomnography. Of the 2168 polysomnographic
    recordings, 60 (3%) had technical problems resulting in insufficient data; 54
    participants underwent a second recording and six people declined. 41 individuals
    with a total sleep time less than 4 h were excluded because of the risk of an
    unbalanced representation of different sleep stages and positions; therefore,
    2121 polysomno-graphic recordings were included in the analysis, and these people
    comprised the HypnoLaus cohort. presents demographic and clinical characterisitics
    of the study cohort.
  id: totrans-split-73
  prefs: []
  type: TYPE_NORMAL
  zh: 2009年9月1日至2013年6月30日期间，从CoLaus/PsyCoLaus研究队列中连续抽取的3043名受试者被邀请在家中进行多导睡眠图记录（[附录
    p 1](#FN2)）。其中，2168名（71%）受试者接受了邀请并进行了多导睡眠图记录。在2168份多导睡眠图记录中，60份（3%）由于技术问题导致数据不足；54名受试者进行了第二次记录，而6人拒绝了。由于睡眠时长少于4小时的风险，排除了41名受试者，以避免不同睡眠阶段和姿势的不平衡表现；因此，分析中包括了2121份多导睡眠图记录，这些人构成了HypnoLaus队列。显示了研究队列的人口统计学和临床特征。
- en: Table 1
  id: totrans-split-74
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 表 1
- en: Demographic and clinical characteristics of participants
  id: totrans-split-75
  prefs: []
  type: TYPE_NORMAL
  zh: 受试者的人口统计学和临床特征
- en: '|  | Total (n=2121) | Men (n=1024) | Women (n=1097) | p value^* |'
  id: totrans-split-76
  prefs: []
  type: TYPE_TB
  zh: '|  | 总数（n=2121） | 男性（n=1024） | 女性（n=1097） | p 值^* |'
- en: '| :-- | :-: | :-: | :-: | :-- |'
  id: totrans-split-77
  prefs: []
  type: TYPE_TB
  zh: '| :-- | :-: | :-: | :-: | :-- |'
- en: '| Age (years) | 57 (49–68) | 56 (49–67) | 58 (50–69) | 0·0263 |'
  id: totrans-split-78
  prefs: []
  type: TYPE_TB
  zh: '| 年龄（岁） | 57（49–68） | 56（49–67） | 58（50–69） | 0·0263 |'
- en: '|   ≥40 to <60 | 1219 (57%) | 613 (60%) | 606 (55%) | .. |'
  id: totrans-split-79
  prefs: []
  type: TYPE_TB
  zh: '|   ≥40到<60 | 1219（57%） | 613（60%） | 606（55%） | .. |'
- en: '|   ≥60 | 902 (43%) | 411 (40%) | 491 (45%) | .. |'
  id: totrans-split-80
  prefs: []
  type: TYPE_TB
  zh: '|   ≥60 | 902 (43%) | 411 (40%) | 491 (45%) | .. |'
- en: '|'
  id: totrans-split-81
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-82
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-83
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| BMI (kg/m²) | 25·6 (4·1) | 26·2 (3·7) | 25·1 (4·6) | <0·0001 |'
  id: totrans-split-84
  prefs: []
  type: TYPE_TB
  zh: '| BMI（kg/m²） | 25·6（4·1） | 26·2（3·7） | 25·1（4·6） | <0·0001 |'
- en: '|'
  id: totrans-split-85
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-86
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-87
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Neck circumference (cm) | 36·9 (3·9) | 39·8 (2·8) | 34·1 (2·4) | <0·0001
    |'
  id: totrans-split-88
  prefs: []
  type: TYPE_TB
  zh: '| 颈围（厘米） | 36·9（3·9） | 39·8（2·8） | 34·1（2·4） | <0·0001 |'
- en: '|'
  id: totrans-split-89
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-90
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-91
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Waist-to-hip ratio | 0·92 (0·07) | 0·96 (0·06) | 0·88 (0·06) | <0·0001 |'
  id: totrans-split-92
  prefs: []
  type: TYPE_TB
  zh: '| 腰臀比 | 0·92（0·07） | 0·96（0·06） | 0·88（0·06） | <0·0001 |'
- en: '|'
  id: totrans-split-93
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-94
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-95
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Alcohol use | 560 (26%) | 325 (32%) | 235 (21%) | <0·0001 |'
  id: totrans-split-96
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 | 560（26%） | 325（32%） | 235（21%） | <0·0001 |'
- en: '|'
  id: totrans-split-97
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-98
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-99
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Smoking | 1210 (57%) | 654 (64%) | 556 (51%) | <0·0001 |'
  id: totrans-split-100
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 | 1210（57%） | 654（64%） | 556（51%） | <0·0001 |'
- en: '|'
  id: totrans-split-101
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-102
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-103
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Snoring | 1164 (55%) | 678 (66%) | 486 (44%) | <0·0001 |'
  id: totrans-split-104
  prefs: []
  type: TYPE_TB
  zh: '| 打鼾 | 1164（55%） | 678（66%） | 486（44%） | <0·0001 |'
- en: '|'
  id: totrans-split-105
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-106
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-107
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Hypertension | 877 (41%) | 497 (49%) | 380 (35%) | <0·0001 |'
  id: totrans-split-108
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 | 877（41%） | 497（49%） | 380（35%） | <0·0001 |'
- en: '|'
  id: totrans-split-109
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-110
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-111
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Diabetes | 212 (10%) | 145 (14·%) | 67 (6%) | <0·0001 |'
  id: totrans-split-112
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 | 212（10%） | 145（14%） | 67（6%） | <0·0001 |'
- en: '|'
  id: totrans-split-113
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-114
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-115
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Metabolic syndrome | 641 (30%) | 366 (36%) | 275 (25%) | <0·0001 |'
  id: totrans-split-116
  prefs: []
  type: TYPE_TB
  zh: '| 代谢综合征 | 641（30%） | 366（36%） | 275（25%） | <0·0001 |'
- en: '|'
  id: totrans-split-117
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-118
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-119
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Epworth score | 6 (3–9) | 6 (4–9) | 5 (3–8) | <0·0001 |'
  id: totrans-split-120
  prefs: []
  type: TYPE_TB
  zh: '| Epworth 评分 | 6（3–9） | 6（4–9） | 5（3–8） | <0·0001 |'
- en: '|   >10 | 258 (12%) | 143 (14%) | 115 (10%) | 0·0129 |'
  id: totrans-split-121
  prefs: []
  type: TYPE_TB
  zh: '|   >10 | 258（12%） | 143（14%） | 115（10%） | 0·0129 |'
- en: '|'
  id: totrans-split-122
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-123
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-124
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| PSQI score | 4 (3–7) | 4 (3–6) | 5 (3–7) | <0·0001 |'
  id: totrans-split-125
  prefs: []
  type: TYPE_TB
  zh: '| PSQI 评分 | 4（3–7） | 4（3–6） | 5（3–7） | <0·0001 |'
- en: '|'
  id: totrans-split-126
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-127
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-128
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Berlin score ≥2 | 525 (25%) | 315 (31%) | 210 (19%) | <0·0001 |'
  id: totrans-split-129
  prefs: []
  type: TYPE_TB
  zh: '| Berlin 评分 ≥2 | 525（25%） | 315（31%） | 210（19%） | <0·0001 |'
- en: Compared with the whole CoLaus/PsyCoLaus cohort, individuals who underwent polysomnography
    were similar in terms of age, sex, body-mass index (BMI), and ethnic origin, and
    they were representative of Lausanne’s general population.^([22](#R22)) However,
    some mild differences were noted between the two cohorts with respect to scores
    on the Pittsburgh sleep quality index, the Epworth sleepiness scale, and the Berlin
    questionnaire for sleep-disordered breathing ([appendix p 3](#FN2)).
  id: totrans-split-130
  prefs: []
  type: TYPE_NORMAL
  zh: 与整个CoLaus/PsyCoLaus队列相比，接受多导睡眠记录的个体在年龄、性别、体重指数（BMI）和种族起源方面相似，并且代表洛桑的一般人口^([22](#R22))。然而，两个队列在匹兹堡睡眠质量指数、Epworth嗜睡量表和柏林睡眠呼吸障碍问卷的得分上存在轻微差异（[附录p
    3](#FN2)）。
- en: In the total HypnoLaus Study cohort, hypopnoea was the most common respiratory
    event (75%), followed by obstructive sleep apnoea (19%), central apnoea (4%),
    and mixed apnoea (2%). To assess a possible first-night effect, the first 20 participants
    underwent two consecutive polysomnographic recordings at home. The type and severity
    of respiratory events and sleep quality were similar between the two nights (data
    not shown).
  id: totrans-split-131
  prefs: []
  type: TYPE_NORMAL
  zh: 在总体HypnoLaus研究队列中，呼吸暂停是最常见的呼吸事件（75%），其次是阻塞性睡眠呼吸暂停（19%）、中枢性呼吸暂停（4%）和混合型呼吸暂停（2%）。为评估可能的首夜效应，首批20名参与者在家中连续进行了两次多导睡眠记录。两晚间的呼吸事件类型、严重程度和睡眠质量相似（未显示数据）。
- en: shows the prevalence of sleep-disordered breathing according to clinically defined
    categories (mild, moderate, and severe) in men and women. An apnoea-hypopnoea
    index of five or more events per h (ie, mild-to-severe sleep-disordered breathing)
    was recorded in 858 (83·8%; 95% CI 81·4–86·0) men and 667 (60·8%; 57·8–63·7) women,
    whereas an apnoea-hypopnoea index of 15 or more events per h (moderate-to-severe
    sleep-disordered breathing) was noted in 509 (49·7%; 46·6–52·8) men and 257 (23·4%;
    20·9–26·0) women. To assess the effect of age on prevalence of sleep-disordered
    breathing, we divided our population into two age categories, younger than 60
    years and 60 years or older, which is roughly the median age of the total participants.
    Moderate-to-severe sleep-disordered breathing increased significantly in older
    participants compared with those in the younger age group, but this difference
    in prevalence seems to be less important for sleep apnoea syndrome ().
  id: totrans-split-132
  prefs: []
  type: TYPE_NORMAL
  zh: 显示了男性和女性在临床定义的类别（轻度、中度和重度）中睡眠呼吸障碍的患病率。每小时五次或更多的呼吸暂停-低通气指数（即轻度到重度睡眠呼吸障碍）记录在858名男性（83·8%;
    95% CI 81·4–86·0）和667名女性（60·8%; 57·8–63·7），而每小时15次或更多的呼吸暂停-低通气指数（中度到重度睡眠呼吸障碍）分别记录在509名男性（49·7%;
    46·6–52·8）和257名女性（23·4%; 20·9–26·0）。为评估年龄对睡眠呼吸障碍患病率的影响，我们将参与者分为两个年龄组，即60岁以下和60岁及以上，这大致是总体参与者的中位年龄。与年轻年龄组相比，老年参与者中中度到重度睡眠呼吸障碍的患病率显著增加，但在睡眠呼吸暂停综合征的患病率方面，这种患病率差异似乎不那么重要（）。
- en: '**Prevalence of sleep-disordered breathing and sleep apnoea syndrome, according
    to age and sex**'
  id: totrans-split-133
  prefs: []
  type: TYPE_NORMAL
  zh: '**睡眠呼吸障碍和睡眠呼吸暂停综合征的患病率，按年龄和性别分类**'
- en: (A) Mild sleep-disordered breathing was defined as ≥5 to <15 events per h, moderate
    was ≥15 to <30 events per h, and severe was ≥30 events per h. Sleep-disordered
    breathing categories differed by age; p<0·0001 in men and p<0·0001 in women. (B)
    Mild sleep apnoea syndrome was defined as ≥5 to <15 events per h and an Epworth
    score >10, moderate was ≥15 to <30 events per h and an Epworth score >10, and
    severe was ≥30 events per h and an Epworth score >10\. Categories of sleep apnoea
    syndrome differed by age; p<0·0001 in men and p<0·0001 in women.
  id: totrans-split-134
  prefs: []
  type: TYPE_NORMAL
  zh: （A）轻度睡眠呼吸障碍定义为每小时≥5到<15次事件，中度睡眠呼吸障碍定义为每小时≥15到<30次事件，重度睡眠呼吸障碍定义为每小时≥30次事件。睡眠呼吸障碍类别按年龄不同而异；男性p<0·0001，女性p<0·0001。（B）轻度睡眠呼吸暂停综合征定义为每小时≥5到<15次事件和Epworth分数>10，中度睡眠呼吸暂停综合征定义为每小时≥15到<30次事件和Epworth分数>10，重度睡眠呼吸暂停综合征定义为每小时≥30次事件和Epworth分数>10。睡眠呼吸暂停综合征类别按年龄不同而异；男性p<0·0001，女性p<0·0001。
- en: The main risk factors associated with presence of sleep-disordered breathing
    were sex, age, BMI, neck circumference, waist-to-hip ratio (in women), and snoring
    (). However, no association was noted between severity of sleep-disordered breathing
    and presence of daytime sleepiness, measured with the Epworth sleepiness scale.
  id: totrans-split-135
  prefs: []
  type: TYPE_NORMAL
  zh: 与睡眠呼吸障碍的存在相关的主要风险因素包括性别、年龄、BMI、颈围、腰臀比（女性）和打鼾（）。然而，白天嗜睡程度（通过Epworth嗜睡量表测量）与睡眠呼吸障碍的严重程度之间没有发现关联。
- en: Table 2
  id: totrans-split-136
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 表2
- en: Risk of sleep-disordered breathing according to related factors, by severity
  id: totrans-split-137
  prefs: []
  type: TYPE_NORMAL
  zh: 睡眠呼吸障碍的风险与相关因素及其严重程度
- en: '|  | Men | Women |'
  id: totrans-split-138
  prefs: []
  type: TYPE_TB
  zh: '|  | 男性 | 女性 |'
- en: '| :-- | :-- | :-- |'
  id: totrans-split-139
  prefs: []
  type: TYPE_TB
  zh: '| :-- | :-- | :-- |'
- en: '|  |'
  id: totrans-split-140
  prefs: []
  type: TYPE_TB
  zh: '|  |'
- en: '* * *'
  id: totrans-split-141
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-142
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-143
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-144
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| :-- | :-: | :-: |'
  id: totrans-split-145
  prefs: []
  type: TYPE_TB
  zh: '| :-- | :-: | :-: |'
- en: '|  | Mild-to-severe | p value | Moderate-to-severe | p value | Mild-to-severe
    | p value | Moderate-to-severe | p value |'
  id: totrans-split-146
  prefs: []
  type: TYPE_TB
  zh: '|  | 轻度至重度 | p 值 | 中度至重度 | p 值 | 轻度至重度 | p 值 | 中度至重度 | p 值 |'
- en: '| :-- | :-: | :-: | :-: | :-: | :-: | :-: | :-: | :-: |'
  id: totrans-split-147
  prefs: []
  type: TYPE_TB
  zh: '| :-- | :-: | :-: | :-: | :-: | :-: | :-: | :-: | :-: |'
- en: '| Age (per 10-year increment) | 1·32 (1·13–1·52) | 0·0008 | 1·53 (1·38–1·68)
    | <0·0001 | 1·72 (1·53–1·90) | <0·0001 | 1·72 (1·50–1·94) | <0·0001 |'
  id: totrans-split-148
  prefs: []
  type: TYPE_TB
  zh: '| 年龄（每 10 年增加） | 1·32 (1·13–1·52) | 0·0008 | 1·53 (1·38–1·68) | <0·0001 | 1·72
    (1·53–1·90) | <0·0001 | 1·72 (1·50–1·94) | <0·0001 |'
- en: '|'
  id: totrans-split-149
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-150
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-151
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| BMI (kg/m²) |  |  |  |  |  |  |  |  |'
  id: totrans-split-152
  prefs: []
  type: TYPE_TB
  zh: '| BMI（kg/m²） |  |  |  |  |  |  |  |  |'
- en: '|   25–30 (*vs* <25) | 1·82 (1·13–2·91) | 0·0132 | 1·74 (1·16–2·59) | 0·0058
    | 3·25 (2·12–4·97) | <0·0001 | 1·90 (1·16–3·12) | 0·0110 |'
  id: totrans-split-153
  prefs: []
  type: TYPE_TB
  zh: '|   25–30 (*vs* <25) | 1·82 (1·13–2·91) | 0·0132 | 1·74 (1·16–2·59) | 0·0058
    | 3·25 (2·12–4·97) | <0·0001 | 1·90 (1·16–3·12) | 0·0110 |'
- en: '|   >30 (*vs* <25) | 4·18 (1·50–11·7) | 0·0062 | 2·84 (1·51–5·34) | 0·0012
    | 2·43 (1·23–4·82) | 0·0110 | 1·75 (0·87–3·54) | 0·1171 |'
  id: totrans-split-154
  prefs: []
  type: TYPE_TB
  zh: '|   >30 (*vs* <25) | 4·18 (1·50–11·7) | 0·0062 | 2·84 (1·51–5·34) | 0·0012
    | 2·43 (1·23–4·82) | 0·0110 | 1·75 (0·87–3·54) | 0·1171 |'
- en: '|'
  id: totrans-split-155
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-156
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-157
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Neck circumference (per 1 cm increment) | 1·02 (0·93–1·13) | 0·6296 | 1·11
    (1·03–1·20) | 0·0044 | 1·07 (0·97–1·17) | 0·1685 | 1·14 (1·03–1·26) | 0·0135 |'
  id: totrans-split-158
  prefs: []
  type: TYPE_TB
  zh: '| 颈围（每增加 1 厘米） | 1·02 (0·93–1·13) | 0·6296 | 1·11 (1·03–1·20) | 0·0044 | 1·07
    (0·97–1·17) | 0·1685 | 1·14 (1·03–1·26) | 0·0135 |'
- en: '|'
  id: totrans-split-159
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-160
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-161
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Waist-to-hip ratio (per quartile increment)^* |  |  |  |  |  |  |  |  |'
  id: totrans-split-162
  prefs: []
  type: TYPE_TB
  zh: '| 腰臀比（每四分位增加）^* |  |  |  |  |  |  |  |  |'
- en: '|   Quartile 2 (*vs* quartile 1) | 1·16 (0·72–1·86) | 0·5376 | 1·35 (0·88–2·06)
    | 0·4681 | 1·47 (0·93–2·32) | 0·0951 | 1·27 (0·67–2·39) | 0·4657 |'
  id: totrans-split-163
  prefs: []
  type: TYPE_TB
  zh: '| 四分位数 2 (*vs* 四分位数 1) | 1·16 (0·72–1·86) | 0·5376 | 1·35 (0·88–2·06) | 0·4681
    | 1·47 (0·93–2·32) | 0·0951 | 1·27 (0·67–2·39) | 0·4657 |'
- en: '|   Quartile 3 (*vs* quartile 1) | 1·54 (0·86–2·78) | 0·1490 | 1·22 (0·77–1·93)
    | 0·4017 | 1·72 (1·10–2·69) | 0·0176 | 1·86 (1·04–3·34) | 0·0376 |'
  id: totrans-split-164
  prefs: []
  type: TYPE_TB
  zh: '| 四分位数 3 (*vs* 四分位数 1) | 1·54 (0·86–2·78) | 0·1490 | 1·22 (0·77–1·93) | 0·4017
    | 1·72 (1·10–2·69) | 0·0176 | 1·86 (1·04–3·34) | 0·0376 |'
- en: '|   Quartile 4 (*vs* quartile 1) | 1·82 (0·94–3·50) | 0·0738 | 1·47 (0·92–2·37)
    | 0·1098 | 1·76 (1·02–3·04) | 0·0406 | 1·85 (0·98–3·52) | 0·0595 |'
  id: totrans-split-165
  prefs: []
  type: TYPE_TB
  zh: '| 四分位数 4 (*vs* 四分位数 1) | 1·82 (0·94–3·50) | 0·0738 | 1·47 (0·92–2·37) | 0·1098
    | 1·76 (1·02–3·04) | 0·0406 | 1·85 (0·98–3·52) | 0·0595 |'
- en: '|'
  id: totrans-split-166
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-167
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-168
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Alcohol use (yes *vs* no)^† | 0·86 (0·57–1·29) | 0·4550 | 1·02 (0·74–1·41)
    | 0·8969 | 0·75 (0·50–1·13) | 0·1647 | 0·84 (0·51–1·40) | 0·5092 |'
  id: totrans-split-169
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒（是 *vs* 否）^† | 0·86 (0·57–1·29) | 0·4550 | 1·02 (0·74–1·41) | 0·8969 |
    0·75 (0·50–1·13) | 0·1647 | 0·84 (0·51–1·40) | 0·5092 |'
- en: '|'
  id: totrans-split-170
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-171
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-172
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Epworth (>10 *vs* ≤10) | 1·02 (0·97–1·07) | 0·5367 | 1·01 (0·97–1·05) | 0·6826
    | 0·98 (0·93–1·02) | 0·3451 | 0·99 (0·94–1·05) | 0·8542 |'
  id: totrans-split-173
  prefs: []
  type: TYPE_TB
  zh: '| Epworth (>10 *vs* ≤10) | 1·02 (0·97–1·07) | 0·5367 | 1·01 (0·97–1·05) | 0·6826
    | 0·98 (0·93–1·02) | 0·3451 | 0·99 (0·94–1·05) | 0·8542 |'
- en: '|'
  id: totrans-split-174
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-175
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-176
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Snoring (yes *vs* no) | 1·67 (1·09–2·57) | 0·0187 | 2·29 (1·55–3·38) | <0·0001
    | 2·34 (1·63–3·36) | 0·0001 | 3·39 (2·07–5·54) | <0·0001 |'
  id: totrans-split-177
  prefs: []
  type: TYPE_TB
  zh: '| 打鼾（是 *vs* 否） | 1·67 (1·09–2·57) | 0·0187 | 2·29 (1·55–3·38) | <0·0001 | 2·34
    (1·63–3·36) | 0·0001 | 3·39 (2·07–5·54) | <0·0001 |'
- en: '|'
  id: totrans-split-178
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-179
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-180
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Berlin score (≥2 *vs*<2) | 1·31 (0·79–2·17) | 0·2964 | 1·25 (0·87–1·79) |
    0·2319 | 1·64 (0·99–2·71) | 0·0531 | 1·69 (1·05–2·70) | 0·0300 |'
  id: totrans-split-181
  prefs: []
  type: TYPE_TB
  zh: '| Berlin 评分 (≥2 *vs* <2) | 1·31 (0·79–2·17) | 0·2964 | 1·25 (0·87–1·79) | 0·2319
    | 1·64 (0·99–2·71) | 0·0531 | 1·69 (1·05–2·70) | 0·0300 |'
- en: Compared with women, scores on the apnoea-hypopnoea index were around three
    times higher in men in the younger age category (≥40 to <60 years) and twice as
    high in older men (≥60 years; ). 305 (49%) women younger than 60 years were postmenopausal,
    and this number rose to 490 (100%) in those 60 years or older. Median scores on
    the apnoea-hypopnoea index were significantly lower in premenopausal women (2·8
    [IQR 1·5–7·5] events per h) compared with postmenopausal women (8·7 [4·2–16·9];
    p<0·0001). Compared with men with moderate-to-severe sleep-disordered breathing,
    women in this category were older (67 years [IQR 57–73] *vs* 62 years [53–70];
    p<0·0001) and had a lower Epworth score (mean 5·6 [SD 3·6] *vs* 6·6 [3·8]; p=0·0005).
    Men and women in the moderate-to-severe category had similar BMI (mean 27·6 kg/m²
    [SD 5·1] *vs* 27·2 kg/m² [3·7], p=0·24), but women had a smaller neck circumference
    (mean 35·3 cm [SD 2·6] *vs* 40·6 cm [2·8]; p<0·0001) and a lower waist-to-hip
    ratio (mean 0·90 [SD 0·06] *vs* 0·97 [0·05]; p<0·0001).
  id: totrans-split-182
  prefs: []
  type: TYPE_NORMAL
  zh: 在年龄在 40 岁以上至 60 岁以下的类别中，与女性相比，男性的阻塞性睡眠呼吸暂停指数评分约高出三倍，而在年龄在 60 岁以上的男性中，高出两倍。49%
    的年龄在 60 岁以下的女性是绝经后，而这一比例在年龄在 60 岁以上的女性中升至 100%。与绝经前女性相比，绝经后女性的阻塞性睡眠呼吸暂停指数中位数评分显著较低（分别为
    2·8 [IQR 1·5–7·5] 事件每小时与 8·7 [4·2–16·9]; p<0·0001）。与中度至重度睡眠障碍的男性相比，此类别中的女性年龄较大（中位数为
    67 岁 [IQR 57–73] *vs* 62 岁 [53–70]; p<0·0001），且 Epworth 评分较低（平均 5·6 [SD 3·6] *vs*
    6·6 [3·8]; p=0·0005）。在中度至重度分类中，男女性的 BMI 相似（平均为 27·6 kg/m² [SD 5·1] *vs* 27·2 kg/m²
    [3·7]，p=0·24），但女性的颈围较小（平均 35·3 厘米 [SD 2·6] *vs* 40·6 厘米 [2·8]; p<0·0001），腰臀比较低（平均
    0·90 [SD 0·06] *vs* 0·97 [0·05]; p<0·0001）。
- en: Table 3
  id: totrans-split-183
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 表 3
- en: Scores on the apnoea-hypopnoea index and oxygen desaturation index, by sex and
    age
  id: totrans-split-184
  prefs: []
  type: TYPE_NORMAL
  zh: 呼吸暂停-低通气指数和氧饱和度下降指数得分，按性别和年龄
- en: '|  | Total | Men | Women | p value^* |'
  id: totrans-split-185
  prefs: []
  type: TYPE_TB
  zh: '|  | 总计 | 男性 | 女性 | p 值^* |'
- en: '| :-- | :-: | :-: | :-: | :-- |'
  id: totrans-split-186
  prefs: []
  type: TYPE_TB
  zh: '| :-- | :-: | :-: | :-: | :-- |'
- en: '| **Apnoea-hypopnoea index (events per h)** |'
  id: totrans-split-187
  prefs: []
  type: TYPE_TB
  zh: '| **呼吸暂停-低通气指数（每小时事件数）** |'
- en: '|'
  id: totrans-split-188
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-189
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-190
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Total | 9·9 (4·2–20·6) | 14·9 (7·2–27·1) | 6·9 (2·7–14·1) | <0·0001 |'
  id: totrans-split-191
  prefs: []
  type: TYPE_TB
  zh: '| 总计 | 9·9（4·2–20·6） | 14·9（7·2–27·1） | 6·9（2·7–14·1） | <0·0001 |'
- en: '|   Age ≥40 to <60 years | 7·6 (2·9–15·9) | 11·7 (6·1–21·1) | 4·3 (1·9–9·3)
    | <0·0001 |'
  id: totrans-split-192
  prefs: []
  type: TYPE_TB
  zh: '|   年龄 ≥40 至 <60 岁 | 7·6（2·9–15·9） | 11·7（6·1–21·1） | 4·3（1·9–9·3） | <0·0001
    |'
- en: '|   Age ≥60 years | 14·3 (7·0–27·2) | 21·1 (9·4–35·6) | 10·8 (5·5–20·0) | <0·0001
    |'
  id: totrans-split-193
  prefs: []
  type: TYPE_TB
  zh: '|   年龄 ≥60 岁 | 14·3（7·0–27·2） | 21·1（9·4–35·6） | 10·8（5·5–20·0） | <0·0001 |'
- en: '|   p value^† | <0·0001 | <0·0001 | <0·0001 | .. |'
  id: totrans-split-194
  prefs: []
  type: TYPE_TB
  zh: '|   p 值^† | <0·0001 | <0·0001 | <0·0001 | .. |'
- en: '|'
  id: totrans-split-195
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-196
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-197
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| **3% oxygen desaturation index (events per h)** |'
  id: totrans-split-198
  prefs: []
  type: TYPE_TB
  zh: '| **3%氧饱和度下降指数（每小时事件数）** |'
- en: '|'
  id: totrans-split-199
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-200
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-201
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Total | 9·9 (4·3–19·4) | 14·4 (6·9–24·9) | 6·9 (2·9–13·5) | <0·0001 |'
  id: totrans-split-202
  prefs: []
  type: TYPE_TB
  zh: '| 总计 | 9·9（4·3–19·4） | 14·4（6·9–24·9） | 6·9（2·9–13·5） | <0·0001 |'
- en: '|   Age ≥40 to <60 years | 7·3 (3·2–15·0) | 11·4 (5·9–20·0) | 4·4 (1·9–9·3)
    | <0·0001 |'
  id: totrans-split-203
  prefs: []
  type: TYPE_TB
  zh: '|   年龄 ≥40 至 <60 岁 | 7·3（3·2–15·0） | 11·4（5·9–20·0） | 4·4（1·9–9·3） | <0·0001
    |'
- en: '|   Age ≥60 years | 13·8 (7·0–26·1) | 19·5 (9·9–32·8) | 11·0 (5·4–19·5) | <0·0001
    |'
  id: totrans-split-204
  prefs: []
  type: TYPE_TB
  zh: '|   年龄 ≥60 岁 | 13·8（7·0–26·1） | 19·5（9·9–32·8） | 11·0（5·4–19·5） | <0·0001 |'
- en: '|   p value^† | <0·0001 | <0·0001 | <0·0001 | .. |'
  id: totrans-split-205
  prefs: []
  type: TYPE_TB
  zh: '|   p 值^† | <0·0001 | <0·0001 | <0·0001 | .. |'
- en: '|'
  id: totrans-split-206
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-207
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-208
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| **4% oxygen desaturation index (events per h)** |'
  id: totrans-split-209
  prefs: []
  type: TYPE_TB
  zh: '| **4%氧饱和度下降指数（每小时事件数）** |'
- en: '|'
  id: totrans-split-210
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '* * *'
  id: totrans-split-211
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: '|'
  id: totrans-split-212
  prefs: []
  type: TYPE_NORMAL
  zh: '|'
- en: '| Total | 4·0 (1·2–10·1) | 6·4 (2·3–14·25) | 2·4 (0·7–6·5) | <0·0001 |'
  id: totrans-split-213
  prefs: []
  type: TYPE_TB
  zh: '| 总计 | 4·0（1·2–10·1） | 6·4（2·3–14·25） | 2·4（0·7–6·5） | <0·0001 |'
- en: '|   Age ≥40 to <60 years | 2·7 (0·7–6·9) | 4·7 (1·6–10·6) | 1·3 (0·3–3·9) |
    <0·0001 |'
  id: totrans-split-214
  prefs: []
  type: TYPE_TB
  zh: '|   年龄 ≥40 至 <60 岁 | 2·7（0·7–6·9） | 4·7（1·6–10·6） | 1·3（0·3–3·9） | <0·0001
    |'
- en: '|   Age ≥60 years | 6·6 (2·5–15·6) | 9·9 (3·9–21·1) | 4·9 (1·9–10·3) | <0·0001
    |'
  id: totrans-split-215
  prefs: []
  type: TYPE_TB
  zh: '|   年龄 ≥60 岁 | 6·6（2·5–15·6） | 9·9（3·9–21·1） | 4·9（1·9–10·3） | <0·0001 |'
- en: '|   p value^† | <0·0001 | <0·0001 | <0·0001 | .. |'
  id: totrans-split-216
  prefs: []
  type: TYPE_TB
  zh: '|   p 值^† | <0·0001 | <0·0001 | <0·0001 | .. |'
- en: shows the association between severity of sleep-disordered breathing and risk
    of diabetes, hypertension, metabolic syndrome, and depression using four models
    with progressive adjustments. Adjusting for BMI (in model 3) significantly decreased
    the associations between sleep-disordered breathing and diabetes, hypertension,
    and metabolic syndrome. Conversely, adjusting for age and sex revealed an association
    between depression and sleep-disordered breathing in model 2\. In the fully adjusted
    models (model 4), the upper quartile of the apnoea-hypopnoea index (Q4, >20·6
    events per h) was associated independently with the presence of hypertension (odds
    ratio 1·60, 95% CI 1·14–2·26; p=0·0292 for trend across severity quartiles), diabetes
    (2·00, 1·05–3·99; p=0·0467), metabolic syndrome (2·80, 1·86–4·29; p<0·0001), and
    depression (1·92, 1·01–3·64; p=0·0292). The interaction term BMI × apnoea-hypopnoea
    index for hypertension (p=0·875), diabetes (p=0·490), and metabolic syndrome (p=0·382)
    was not included in these models because they were not significant. Using the
    apnoea-hypopnoea index as a continuous variable in the same fully adjusted regression
    models led to similar independent associations with diabetes (p=0·0119), metabolic
    syndrome (p<0·0001), hypertension (p=0·0098), and depression (p=0·0260).
  id: totrans-split-217
  prefs: []
  type: TYPE_NORMAL
  zh: 显示了四种逐步调整模型中睡眠呼吸紊乱严重程度与糖尿病、高血压、代谢综合征和抑郁症的关联。在第三模型中，BMI的调整显著降低了睡眠呼吸紊乱与糖尿病、高血压和代谢综合征之间的关联。相反，在第二模型中，年龄和性别的调整显示出抑郁症与睡眠呼吸紊乱的关联。在完全调整的模型（第四模型）中，呼吸暂停-低通气指数的上四分位数（Q4，每小时>20·6次事件）独立与高血压（比值比1·60，95%
    CI 1·14–2·26；p=0·0292，趋势跨严重度四分位数），糖尿病（2·00，1·05–3·99；p=0·0467），代谢综合征（2·80，1·86–4·29；p<0·0001）和抑郁症（1·92，1·01–3·64；p=0·0292）相关联。BMI
    × 呼吸暂停-低通气指数的相互作用项对高血压（p=0·875）、糖尿病（p=0·490）和代谢综合征（p=0·382）在这些模型中未显著，因此未包含在内。在相同的完全调整回归模型中使用呼吸暂停-低通气指数作为连续变量显示与糖尿病（p=0·0119）、代谢综合征（p<0·0001）、高血压（p=0·0098）和抑郁症（p=0·0260）的类似独立关联。
- en: '**Estimated risk for diabetes, metabolic syndrome, hypertension, and depression
    associated with severity of sleep-disordered breathing**'
  id: totrans-split-218
  prefs: []
  type: TYPE_NORMAL
  zh: '**与睡眠呼吸紊乱严重程度相关的糖尿病、代谢综合征、高血压和抑郁症的预计风险**'
- en: 'Circles represent the odds ratio and bars the 95% CI. If bars cross the dotted
    line at 1·0, risk is not significant. Apnoea-hypopnoea index severity quartiles
    are defined as: Q1, 0–4·2 events per h; Q2, 4·3–9·9 events per h; Q3, 10·0–20·6
    events per h; and Q4, >20·6 events per h. p values are for trend across severity
    quartiles. For diabetes, metabolic syndrome, and hypertension: model 1 was adjusted
    for age and sex; model 2 was adjusted for age, sex, and alcohol and tobacco consumption;
    model 3 was adjusted for age, sex, alcohol and tobacco consumption, and BMI; and
    model 4 was adjusted for age, sex, alcohol and tobacco consumption, BMI, neck
    circumference, and waist-to-hip ratio (except for metabolic syndrome because this
    ratio is part of its definition). For depression: model 1 was raw data; model
    2 was adjusted for age and sex; model 3 was adjusted for age, sex, and use of
    benzodiazepines; and model 4 was adjusted for age, sex, use of benzodiazepines,
    and use of antidepressant drugs.'
  id: totrans-split-219
  prefs: []
  type: TYPE_NORMAL
  zh: 圆圈表示比值比，条形图表示95%的置信区间。如果条形图横穿于虚线1·0处，则风险不显著。呼吸暂停低通气指数严重度四分位定义如下：Q1，每小时0–4·2次事件；Q2，每小时4·3–9·9次事件；Q3，每小时10·0–20·6次事件；Q4，每小时>20·6次事件。p值用于评估严重度四分位之间的趋势。对于糖尿病、代谢综合征和高血压：模型1校正了年龄和性别；模型2校正了年龄、性别、饮酒和吸烟；模型3校正了年龄、性别、饮酒和吸烟、以及BMI；模型4校正了年龄、性别、饮酒和吸烟、BMI、颈围和腰臀比（代谢综合征除外，因为这个比率是其定义的一部分）。对于抑郁症：模型1使用原始数据；模型2校正了年龄和性别；模型3校正了年龄、性别和苯二氮卓类药物的使用；模型4校正了年龄、性别、苯二氮卓类药物的使用和抗抑郁药物的使用。
- en: Discussion
  id: totrans-split-220
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 讨论
- en: To our knowledge, the HypnoLaus Sleep Cohort study is the largest study to assess
    the prevalence of sleep-disordered breathing in a population-based sample using
    the most recent polysomnographic recording techniques and scoring criteria. We
    recorded a much higher than previously estimated prevalence of sleep-disordered
    breathing and an independent association between the disorder and diabetes, hypertension,
    metabolic syndrome, and depression, albeit mainly in the highest severity quartile
    of the apnoea-hypopnoea index (>20·6 events per h).
  id: totrans-split-221
  prefs: []
  type: TYPE_NORMAL
  zh: 据我们所知，HypnoLaus睡眠队列研究是使用最新的多导睡眠记录技术和评分标准，在基于人群的样本中评估睡眠呼吸障碍患病率最大的研究。我们记录了比先前估计的睡眠呼吸障碍患病率高得多，以及该障碍与糖尿病、高血压、代谢综合征和抑郁症之间的独立关联，尽管主要出现在呼吸暂停低通气指数最高严重度四分位（每小时>20·6次事件）中。
- en: The first report of prevalence of sleep-disordered breathing was published 20
    years ago by Young and colleagues^([10](#R10)) and was based on the Wisconsin
    Cohort Study (WSCS). In a follow-up of WSCS, increased prevalence estimates were
    reported.^([13](#R13)) However, the earlier study was not strictly population-based
    because it included an enriched selection of people at risk for sleep-disordered
    breathing (panel). The reported prevalence of sleep-disordered breathing was,
    thus, estimated using models extrapolating the observed results to the general
    US population using demographic data from the National Health and Nutrition Examination
    Survey (NHANES) study.
  id: totrans-split-222
  prefs: []
  type: TYPE_NORMAL
  zh: 首次报道的睡眠呼吸障碍患病率是由Young及其同事^([10](#R10)) 20年前发表，并基于威斯康星队列研究（WSCS）。在WSCS的后续研究中，报告了增加的患病率估计^([13](#R13))。然而，早期研究并非严格基于人群，因为它包括一个富集选择的有睡眠呼吸障碍风险的人群（面板）。因此，报道的睡眠呼吸障碍患病率是使用模型将观察结果外推到美国全国健康与营养调查（NHANES）研究的人口数据基础上估计的。
- en: The high prevalence of sleep-disordered breathing recorded in our cohort could
    be accounted for by two factors. First, we measured the prevalence of sleep-disordered
    breathing directly in the general population rather than estimating it; and second,
    we used currently recommended techniques (including nasal pressure sensors) and
    scoring criteria. To date, only two studies based directly on samples from the
    general population have been done.^([17](#R17),[18](#R18)) In both studies, researchers
    reported a high prevalence of sleep-disordered breathing. In a study from Spain
    of 2148 individuals aged 30–70 years,^([18](#R18)) the prevalence of sleep-disordered
    breathing (apnoea-hypopnoea index >5 events per h) was 26·2% in men and 28·0%
    in women. However, full polysomnography was only used in a subset of 390 participants,
    and most participants were studied with limited channels recorders without direct
    airflow measurement, which does not match current standards.^([21](#R21)) In a
    study from Brazil of 1042 participants aged 20–80 years,^([17](#R17)) the latest
    breathing sensors were used to measure variation in nasal pressure (which is the
    technique currently used in all modern clinical laboratories). The researchers
    reported a high prevalence of sleep-disordered breathing (apnoea-hypopnoea index
    >5 events per h) of 46·6% in men and 30·5% in women; however, these results were
    obtained in a specific mixed ethnic population and are difficult to generalise
    to other populations.
  id: totrans-split-223
  prefs: []
  type: TYPE_NORMAL
  zh: 我们队列中记录的睡眠呼吸障碍高发率可能由两个因素引起。首先，我们直接在普通人群中测量了睡眠呼吸障碍的发生率，而不是估计它；其次，我们采用了目前推荐的技术（包括鼻压传感器）和评分标准。迄今为止，只有两项直接基于普通人群样本的研究已经完成^([17](#R17),[18](#R18))。在这两项研究中，研究人员报告了睡眠呼吸障碍的高发生率。在一项来自西班牙的研究中，涵盖了30至70岁的2148名个体^([18](#R18))，睡眠呼吸障碍（呼吸暂停-低通气指数每小时>5次）在男性中为26·2％，在女性中为28·0％。然而，全面的多导睡眠图仅在390名参与者的子集中使用，并且大多数参与者是使用有限通道记录仪进行研究，未直接测量气流，这与当前标准不符^([21](#R21))。在一项来自巴西的研究中，涵盖了20至80岁的1042名参与者^([17](#R17))，最新的呼吸传感器被用来测量鼻压变化（这是目前所有现代临床实验室中使用的技术）。研究人员报告了睡眠呼吸障碍的高发生率（呼吸暂停-低通气指数每小时>5次），男性为46·6％，女性为30·5％；然而，这些结果是在特定混合种群中获得的，难以推广到其他人群。
- en: The findings of these studies and ours suggest that the prevalence of sleep-disordered
    breathing is highly dependent on technical factors. Nasal pressure sensors detect
    subtle breathing variations, resulting in detection of more hypopnoea events (and,
    therefore, a higher apnoea-hypopnoea index) than with thermistors, which have
    decreased sensitivity ([appendix p 2](#FN2)).^([27](#R27),[28](#R28)) The 2012
    AASM criteria^([21](#R21)) propose a more liberal definition of hypopnoea, whereas
    more strict definitions were used in previous studies. Although this change in
    definition might partly account for the increased prevalence of sleep-disordered
    breathing in our study, prevalence was still higher than previously reported after
    rescoring the polysomnographic recordings using the older and more restrictive
    criteria ([appendix p 4](#FN2)).
  id: totrans-split-224
  prefs: []
  type: TYPE_NORMAL
  zh: 这些研究以及我们的研究结果表明，睡眠呼吸障碍的发生率高度依赖技术因素。鼻压传感器可以检测到微小的呼吸变化，导致检测到更多的低通气事件（因此，更高的呼吸暂停-低通气指数），而热敏传感器的灵敏度降低了（见附录p
    2^([FN2](#FN2))）。2012年AASM标准^([21](#R21))提出了对低通气的更宽松定义，而以前的研究使用了更严格的定义。尽管这种定义的变化可能部分解释了我们研究中睡眠呼吸障碍的发生率增加，但在使用旧的更严格标准重新评分多导睡眠图记录后，其发生率仍高于以前的报告（见附录p
    4^([FN2](#FN2))）。
- en: In our study, clinical and epidemiological factors associated with sleep-disordered
    breathing were increasing age, male sex, large neck circum ference, obesity, and
    reported snoring, similar to previous studies.^([10](#R10),[12](#R12),[29](#R29))
    The difference in prevalence of sleep-disordered breathing between men and women
    seemed to diminish in participants aged 60 years or older, probably because of
    the increased proportion of postmenopausal women in this age category, who had
    a higher median apnoea-hypopnoea index compared with premenopausal women. Even
    though women and men with an apnoea-hypopnoea index of 15 or more events per h
    had a similar BMI, women had a lower neck circumference and waist-to-hip ratio
    compared with men. This finding confirms that not only central obesity but also
    hormonal status affects the prevalence of sleep-disordered breathing in women.
  id: totrans-split-225
  prefs: []
  type: TYPE_NORMAL
  zh: 在我们的研究中，与睡眠呼吸障碍相关的临床和流行病学因素包括年龄增长、男性、颈围增大、肥胖以及自报打鼾，与先前的研究相似^([10](#R10),[12](#R12),[29](#R29))。男性和女性之间睡眠呼吸障碍的患病率差异在60岁及以上的参与者中似乎减少，可能是由于此年龄组中更多处于更年期的女性比例增加，这些女性的中位无气-低呼吸指数比更年前女性更高。尽管具有每小时15次或更多事件的无气-低呼吸指数的女性和男性具有相似的BMI，但与男性相比，女性的颈围和腰臀比较低。这一发现证实，不仅中心性肥胖，而且激素状态也影响女性睡眠呼吸障碍的患病率。
- en: 'Independent associations between severity of sleep-disordered breathing and
    diabetes, hypertension, metabolic syndrome, and depression were noted after multivariable
    adjustment. This finding suggests that we identified a clinically important disease
    rather than simply over-diagnosing healthy individuals. These results accord with
    findings of the WSCS,^([2](#R2)) in which sleep-disordered breathing was associated
    prospectively with hypertension, a result confirmed by later observational and
    interventional studies.^([30](#R30),[31](#R31)) Moreover, a prospective association
    with depression has been reported previously.^([8](#R8)) Diabetes seems to have
    a bidirectional association with sleep-disordered breathing: intermittent hypoxaemia
    contributes to development of insulin resistance and glucose intolerance, and
    type 2 diabetes increases an individual’s predisposition to sleep-disordered breathing.^([9](#R9),[32](#R32),[33](#R33))
    However, fewer reports have been published of an association between sleep-disordered
    breathing and metabolic syndrome.^([34](#R34))'
  id: totrans-split-226
  prefs: []
  type: TYPE_NORMAL
  zh: 睡眠呼吸障碍的严重程度与糖尿病、高血压、代谢综合征和抑郁之间的独立关联在多变量调整后显著。这一发现表明，我们发现了一个临床上重要的疾病，而不仅仅是对健康个体进行过度诊断。这些结果与WSCS研究的发现一致^([2](#R2))，即睡眠呼吸障碍与高血压有前瞻性关联，这一结果后来的观察性和干预性研究也证实了^([30](#R30),[31](#R31))。此外，先前已报道了与抑郁的前瞻性关联^([8](#R8))。糖尿病似乎与睡眠呼吸障碍有双向关联：间歇性低氧血症导致胰岛素抵抗和葡萄糖耐量的发展，而2型糖尿病增加个体对睡眠呼吸障碍的易感性^([9](#R9),[32](#R32),[33](#R33))。然而，有关睡眠呼吸障碍与代谢综合征关联的报道较少^([34](#R34))。
- en: In previous studies, even sleep-disordered breathing of the lowest severity
    (apnoea-hypopnoea index >5 events per h) was associated with hypertension^([2](#R2),[18](#R18))
    or depression.^([8](#R8)) However, we noted these associations mostly in the upper
    quartile of severity (apnoea-hypopnoea index >20·6 events per h). Since current
    recording techniques and scoring criteria are more sensitive than those used previously,
    this finding strongly suggests that the definition of sleep-disordered breathing
    should be revised. Indeed, in our study, almost every individual had some degree
    of sleep-disordered breathing, and an increasing apnoea-hypopnoea index was associated
    with augmented prevalence of comorbid diseases. These results reinforce the idea
    that, instead of using the arbitrary diagnostic threshold of the apnoea-hypopnoea
    index, sleep-disordered breathing should be considered as a disease characterised
    by a severity spectrum, akin to blood pressure or cholesterol levels. Treatment
    of sleep-disordered breathing should, thus, be increasingly aggressive with rising
    apnoea-hypopnoea index, particularly in individuals with risk factors for comorbidities
    associated with sleep-disordered breathing, such as sleepiness, cardiovascular
    disease, metabolic disease, and depression. Treatments will ultimately be guided
    by appropriately designed clinical trials, but individuals with a low apnoea-hypopnoea
    index and at low risk for comorbidities could be treated conservatively to reduce
    risk factors for sleep-disordered breathing (eg, weight control or avoiding sleep
    in the supine position), whereas individuals at higher risk could benefit from
    continuous positive airway pressure (CPAP), mandibular advancement devices, and
    surgery (eg, maxillomandibular advancement surgery) in selected cases. This rational
    approach to sleep-disordered breathing is implemented de facto by skilled clinicians;
    however, our results emphasise the importance of dedicating health care resources
    to individuals at high risk of complications rather than initiating treatment
    based on an apnoea-hypopnoea index threshold. Ultimately, follow-up of the HypnoLaus
    cohort will allow us to identify individuals at high risk of incident complications
    (eg, using biological or genetic markers) and will help to provide therapeutic
    recommendations in an individualised manner.
  id: totrans-split-227
  prefs: []
  type: TYPE_NORMAL
  zh: 在先前的研究中，即使是最轻度的睡眠呼吸紊乱（呼吸暂停-低通气指数 >5次每小时）也与高血压^([2](#R2),[18](#R18))或抑郁症^([8](#R8))相关联。然而，我们注意到这些关联主要出现在重度程度的上四分位数（呼吸暂停-低通气指数
    >20·6次每小时）。由于当前的记录技术和评分标准比以前使用的更敏感，这一发现强烈表明睡眠呼吸紊乱的定义应该进行修订。事实上，在我们的研究中，几乎每个个体都有一定程度的睡眠呼吸紊乱，并且呼吸暂停-低通气指数的增加与共病疾病的患病率增加有关。这些结果强化了这样一个观点，即睡眠呼吸紊乱应被视为一种疾病，其严重程度谱系类似于血压或胆固醇水平。因此，应该根据个体的风险因素对睡眠呼吸紊乱的治疗采取更为积极的策略，特别是对于那些与睡眠呼吸紊乱相关的共病因素，如嗜睡、心血管疾病、代谢性疾病和抑郁症的个体。最终，治疗将受到适当设计的临床试验的指导，但是那些呼吸暂停-低通气指数低且低风险的个体可以采取保守治疗措施以降低睡眠呼吸紊乱的风险因素（例如体重控制或避免仰卧睡眠），而高风险个体可能会从持续气道正压（CPAP）、下颌前移装置和手术（例如上颌下颌前移手术）中受益。这种对睡眠呼吸紊乱的理性治疗方法实际上已经被熟练的临床医生实施；然而，我们的结果强调了将健康护理资源专注于高风险并发症个体的重要性，而不是基于呼吸暂停-低通气指数阈值启动治疗。最终，对HypnoLaus队列的随访将使我们能够识别出存在高发并发症风险的个体（例如使用生物学或遗传标志物），并将有助于以个体化的方式提供治疗建议。
- en: The major strengths of our study are that it was done in a large, population-based
    sample, enabling extrapolation of findings to the original population. Moreover,
    poly somnographic recordings were done in the participant’s home environment,
    thus minimising the likelihood of information bias. Finally, modern recording
    techniques and scoring criteria were applied, which ensures validity of results
    in view of current recommendations.^([21](#R21))
  id: totrans-split-228
  prefs: []
  type: TYPE_NORMAL
  zh: 我们研究的主要优势在于它是在一个大规模的基于人口的样本中进行的，可以推广研究结果到原始人群。此外，多导睡眠记录是在参与者的家庭环境中完成的，从而最大限度地减少了信息偏倚的可能性。最后，应用了现代记录技术和评分标准，这确保了结果的有效性符合当前的建议^([21](#R21))。
- en: The main limitations of our study are the cross-sectional setting and the inclusion
    of individuals aged 40–85 years old only, almost exclusively of white European
    origin and with a low prevalence of obesity. Thus, generalisation of findings
    to younger people, to populations with a high prevalence of obesity, or to people
    from other ethnic backgrounds is limited. For example, the average BMI is lower
    in Switzerland than in the USA, suggesting that the prevalence of sleep-disordered
    breathing could be higher in a North American population. Second, 29% of participants
    declined to have polysomnography, which might have caused selection bias. However,
    since the HypnoLaus sample was similar in terms of age, sex, BMI, and ethnic origin
    to the CoLaus/PsyCoLaus cohort, which is representative of Lausanne’s general
    population, we believe that our results are probably very close to the true prevalence
    of sleep-disordered breathing in the general population. Finally, a variable time
    gap existed between clinical assessment of participants and polysomnography, but
    it probably did not affect the association between severity of sleep-disordered
    breathing and diabetes, hypertension, metabolic syndrome, and depression, since
    these disorders are typically chronic conditions.
  id: totrans-split-229
  prefs: []
  type: TYPE_NORMAL
  zh: 我们研究的主要局限性是横断面设置和仅包括年龄在40至85岁之间的个体，几乎全为白人欧洲人且肥胖率较低。因此，研究结果推广到年轻人群、肥胖率高的人群或其他种族背景的人群的适用性有限。例如，瑞士的平均BMI低于美国，这表明在北美人群中睡眠呼吸紊乱的患病率可能更高。其次，29%的参与者拒绝进行多导睡眠图检查，这可能导致选择偏倚。然而，由于HypnoLaus样本在年龄、性别、BMI和种族起源上与代表洛桑一般人口的CoLaus/PsyCoLaus队列相似，我们认为我们的结果可能非常接近一般人群中睡眠呼吸紊乱的真实患病率。最后，参与者的临床评估和多导睡眠图检查之间存在可变的时间间隔，但这可能不会影响睡眠呼吸紊乱严重程度与糖尿病、高血压、代谢综合征和抑郁症之间的关联，因为这些疾病通常是慢性病。
- en: The prevalence of sleep-disordered breathing in the general population is considerably
    higher than previously reported when the most recent recording techniques and
    scoring criteria are used. Caution is thus needed when comparing the prevalence
    of sleep-disordered breathing with previous studies in which different sampling
    frames, recording techniques, and scoring criteria were used. These results, and
    the progressive association between severity of sleep-disordered breathing and
    cardiovascular, metabolic, and psychiatric diseases, suggest that an arbitrary
    threshold for the apnoea-hypopnoea index could be hard to define and clinical
    decisions might need a complete clinical picture to be well informed.
  id: totrans-split-230
  prefs: []
  type: TYPE_NORMAL
  zh: 当使用最新的记录技术和评分标准时，一般人群中睡眠呼吸紊乱的患病率显著高于先前报道。因此，在与先前使用不同抽样框架、记录技术和评分标准的研究比较睡眠呼吸紊乱的患病率时需要谨慎。这些结果以及睡眠呼吸紊乱严重程度与心血管、代谢和精神疾病之间的渐进关联，表明定义阻塞-低通气指数的任意阈值可能是困难的，临床决策可能需要完整的临床图片来做出明智的决定。
- en: ​
  id: totrans-split-231
  prefs: []
  type: TYPE_NORMAL
  zh: ​
- en: '*Panel*: Research in context'
  id: totrans-split-232
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: '*面板*：研究背景'
- en: Systematic review
  id: totrans-split-233
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 系统评价
- en: We searched PubMed up to October, 2014, with the terms “sleep apnea”, “sleep
    apnoea”, or “sleep disordered breathing”, and “prevalence”. After exclusion of
    studies that did not include objective nocturnal measurements, we retrieved 21
    epidemiological studies assessing the prevalence of sleep-disordered breathing
    in different populations. Results of epidemiological studies done in the late
    1980s and 1990s showed a rather low prevalence of sleep-disordered breathing,
    probably due to low sensitivity of recording techniques.^([10](#R10),[12](#R12))
    These and almost all subsequent studies included population samples selected or
    enriched with individuals presenting risk factors for sleep-disordered breathing
    or cardiovascular disease, and were thus not representative of the general population.
    Therefore, statistical corrections were needed to estimate the prevalence of sleep-disordered
    breathing in the general population in those studies. Another important factor
    affecting prevalence of sleep-disordered breathing is the definition of respiratory
    events, which strongly affects the apnoea-hypopnoea index (^([appendix p 4](#FN2))).
    Since these definitions were updated in 2012, none of the previous epidemiological
    studies could use the up-to-date definition of respiratory events.
  id: totrans-split-234
  prefs: []
  type: TYPE_NORMAL
  zh: 我们通过PubMed检索至2014年10月，使用术语“sleep apnea”、“sleep apnoea”或“sleep disordered breathing”，以及“prevalence”。在排除未包含客观夜间测量的研究后，我们检索到21项流行病学研究，评估不同人群中睡眠呼吸障碍的流行率。上世纪80年代末和90年代进行的流行病学研究结果显示睡眠呼吸障碍的流行率相对较低，可能是由于记录技术的低敏感性所致。^([10](#R10),[12](#R12))
    这些以及几乎所有后续研究均包括选择或富集了具有睡眠呼吸障碍或心血管疾病风险因素的人群样本，因此并不代表一般人群。因此，需要进行统计校正以估算这些研究中一般人群中睡眠呼吸障碍的流行率。影响睡眠呼吸障碍流行率的另一个重要因素是呼吸事件的定义，这严重影响无氧期-低通气指数
    (^([附录第4页](#FN2)))。由于这些定义在2012年更新，因此以前的流行病学研究都无法使用最新的呼吸事件定义。
- en: Interpretation
  id: totrans-split-235
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 解释
- en: Using the most recent definitions for respiratory events, and diagnostic techniques
    commonly used in all modern sleep laboratories, we noted that almost every individual
    had some degree of sleep-disordered breathing. Moreover, an increasing number
    of apnoea and hypopnoea events per h was associated with augmented comorbidity.
    This finding reinforces the idea that sleep-disordered breathing should be considered
    as a disease with a continuous spectrum, rather than as a definite yes or no diagnosis.
    Individuals at high risk of incident sleep-disordered breathing-related complications
    should be identified so treatment efforts can be focused on them.
  id: totrans-split-236
  prefs: []
  type: TYPE_NORMAL
  zh: 使用所有现代睡眠实验室普遍使用的最新呼吸事件定义和诊断技术，我们注意到几乎每个人都有某种程度的睡眠呼吸障碍。此外，每小时出现的无氧期和低通气事件数增加与合并症增加有关。这一发现强化了睡眠呼吸障碍应被视为具有连续谱系的疾病，而不是明确的是或否诊断。应识别高风险的睡眠呼吸障碍相关并发症患者，以便将治疗重点放在他们身上。
- en: Acknowledgments
  id: totrans-split-237
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 致谢
- en: The HypnoLaus and CoLaus/PsyCoLaus studies were supported by research grants
    from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, the Swiss
    National Science Foundation (grants 3200B0–105993, 3200B0-118308, 33CSCO-122661,
    33CS30-139468, and 33CS30-148401), Leenaards Foundation, and Vaud Pulmonary League
    (Ligue Pulmonaire Vaudoise). We thank the Lausanne population who volunteered
    to participate in the CoLaus/PsyCoLaus and Hypnolaus studies, the whole team of
    CoLaus, and Yannick Goy and Jerome Toriel for technical assistance.
  id: totrans-split-238
  prefs: []
  type: TYPE_NORMAL
  zh: HypnoLaus和CoLaus/PsyCoLaus研究得到了GlaxoSmithKline的研究资助，洛桑生物与医学院，瑞士国家科学基金会（3200B0–105993、3200B0-118308、33CSCO-122661、33CS30-139468和33CS30-148401号资助），Leenaards基金会和沃州肺病联盟（Ligue
    Pulmonaire Vaudoise）的支持。我们感谢洛桑市民自愿参与CoLaus/PsyCoLaus和Hypnolaus研究，整个CoLaus团队以及Yannick
    Goy和Jerome Toriel的技术支持。
- en: Footnotes
  id: totrans-split-239
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 脚注
- en: See **Online** for appendix
  id: totrans-split-240
  prefs: []
  type: TYPE_NORMAL
  zh: 请参见附录的**在线**版本
- en: For more on **R** see [http://www.r-project.org/](http://www.r-project.org/)
  id: totrans-split-241
  prefs: []
  type: TYPE_NORMAL
  zh: 关于**R**的更多信息，请访问[http://www.r-project.org/](http://www.r-project.org/)
- en: '**Contributors** RH and MT designed the HypnoLaus study and are co-principal
    investigators. NT and DA recruited participants and did the sleep studies. DA,
    NT, JH-R, and RH analysed the sleep studies. PV, PM-V, MP, VM, and GW provided
    cardiovascular and metabolic data from the main cohort (CoLaus). PM-V, HM-S, and
    RH did the statistical analysis. RH, JH-R, and AM analysed and interpreted sleep,
    cardiovascular, and metabolic data. RH, SV, and JH-R wrote the report. All authors
    critically reviewed the report.'
  id: totrans-split-242
  prefs: []
  type: TYPE_NORMAL
- en: '**Declaration of interests**'
  id: totrans-split-243
  prefs: []
  type: TYPE_NORMAL
- en: We declare no competing interests.
  id: totrans-split-244
  prefs: []
  type: TYPE_NORMAL
- en: References
  id: totrans-split-245
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 2\.
  id: totrans-split-246
  prefs: []
  type: TYPE_NORMAL
- en: Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association
    between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–1384.
    [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10805822)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Prospective+study+of+the+association+between+sleep-disordered+breathing+and+hypertension&author=PE+Peppard&author=T+Young&author=M+Palta&author=J+Skatrud&volume=342&publication_year=2000&pages=1378-1384&pmid=10805822&)]
  id: totrans-split-247
  prefs: []
  type: TYPE_NORMAL
- en: 3\.
  id: totrans-split-248
  prefs: []
  type: TYPE_NORMAL
- en: 'Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive
    sleep apnea and incident coronary heart disease and heart failure: the sleep heart
    health study. Circulation. 2010;122:352–360. [[PMC free article](/pmc/articles/PMC3117288/)]
    [[PubMed](https://pubmed.ncbi.nlm.nih.gov/20625114)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Circulation&title=Prospective+study+of+obstructive+sleep+apnea+and+incident+coronary+heart+disease+and+heart+failure:+the+sleep+heart+health+study&author=DJ+Gottlieb&author=G+Yenokyan&author=AB+Newman&volume=122&publication_year=2010&pages=352-360&pmid=20625114&)]'
  id: totrans-split-249
  prefs: []
  type: TYPE_NORMAL
- en: 4\.
  id: totrans-split-250
  prefs: []
  type: TYPE_NORMAL
- en: Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive
    sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–2041.
    [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16282178)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Obstructive+sleep+apnea+as+a+risk+factor+for+stroke+and+death&author=HK+Yaggi&author=J+Concato&author=WN+Kernan&author=JH+Lichtman&author=LM+Brass&volume=353&publication_year=2005&pages=2034-2041&pmid=16282178&)]
  id: totrans-split-251
  prefs: []
  type: TYPE_NORMAL
- en: 5\.
  id: totrans-split-252
  prefs: []
  type: TYPE_NORMAL
- en: 'Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea
    and incident stroke: The Sleep Heart Health Study. Am J Respir Crit Care Med.
    2010;182:269–277. [[PMC free article](/pmc/articles/PMC2913239/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/20339144)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Obstructive+sleep+apnea-hypopnea+and+incident+stroke:+The+Sleep+Heart+Health+Study&author=S+Redline&author=G+Yenokyan&author=DJ+Gottlieb&volume=182&publication_year=2010&pages=269-277&pmid=20339144&)]'
  id: totrans-split-253
  prefs: []
  type: TYPE_NORMAL
- en: 6\.
  id: totrans-split-254
  prefs: []
  type: TYPE_NORMAL
- en: 'Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular
    disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am
    J Respir Crit Care Med. 2002;166:159–165. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/12119227)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Increased+incidence+of+cardiovascular+disease+in+middle-aged+men+with+obstructive+sleep+apnea:+a+7-year+follow-up&author=Y+Peker&author=J+Hedner&author=J+Norum&author=H+Kraiczi&author=J+Carlson&volume=166&publication_year=2002&pages=159-165&pmid=12119227&)]'
  id: totrans-split-255
  prefs: []
  type: TYPE_NORMAL
  zh: Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. 阻塞性睡眠呼吸暂停患者中中年男性心血管疾病发生率增加的7年随访研究。Am
    J Respir Crit Care Med. 2002;166:159–165. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/12119227)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Increased+incidence+of+cardiovascular+disease+in+middle-aged+men+with+obstructive+sleep+apnea:+a+7-year+follow-up&author=Y+Peker&author=J+Hedner&author=J+Norum&author=H+Kraiczi&author=J+Carlson&volume=166&publication_year=2002&pages=159-165&pmid=12119227&)]
- en: 7\.
  id: totrans-split-256
  prefs: []
  type: TYPE_NORMAL
  zh: 7\.
- en: 'Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes
    in men with obstructive sleep apnoea-hypopnoea with or without treatment with
    continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–1053.
    [[PubMed](https://pubmed.ncbi.nlm.nih.gov/15781100)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=Long-term+cardiovascular+outcomes+in+men+with+obstructive+sleep+apnoea-hypopnoea+with+or+without+treatment+with+continuous+positive+airway+pressure:+an+observational+study&author=JM+Marin&author=SJ+Carrizo&author=E+Vicente&author=AG+Agusti&volume=365&publication_year=2005&pages=1046-1053&pmid=15781100&)]'
  id: totrans-split-257
  prefs: []
  type: TYPE_NORMAL
  zh: Marin JM, Carrizo SJ, Vicente E, Agusti AG. 长期连续正压通气治疗对阻塞性睡眠呼吸暂停男性患者心血管结局的影响：一项观察性研究。Lancet.
    2005;365:1046–1053. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/15781100)] [[Google
    Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=Long-term+cardiovascular+outcomes+in+men+with+obstructive+sleep+apnoea-hypopnoea+with+or+without+treatment+with+continuous+positive+airway+pressure:+an+observational+study&author=JM+Marin&author=SJ+Carrizo&author=E+Vicente&author=AG+Agusti&volume=365&publication_year=2005&pages=1046-1053&pmid=15781100&)]
- en: 8\.
  id: totrans-split-258
  prefs: []
  type: TYPE_NORMAL
  zh: 8\.
- en: Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related
    breathing disorder and depression. Arch Intern Med. 2006;166:1709–1715. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16983048)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&title=Longitudinal+association+of+sleep-related+breathing+disorder+and+depression&author=PE+Peppard&author=M+Szklo-Coxe&author=KM+Hla&author=T+Young&volume=166&publication_year=2006&pages=1709-1715&pmid=16983048&)]
  id: totrans-split-259
  prefs: []
  type: TYPE_NORMAL
  zh: Peppard PE, Szklo-Coxe M, Hla KM, Young T. 睡眠相关呼吸障碍与抑郁的长期关联。Arch Intern Med.
    2006;166:1709–1715. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16983048)] [[Google
    Scholar](https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&title=Longitudinal+association+of+sleep-related+breathing+disorder+and+depression&author=PE+Peppard&author=M+Szklo-Coxe&author=KM+Hla&author=T+Young&volume=166&publication_year=2006&pages=1709-1715&pmid=16983048&)]
- en: 9\.
  id: totrans-split-260
  prefs: []
  type: TYPE_NORMAL
  zh: 9\.
- en: 'Kendzerska T, Gershon AS, Hawker G, Tomlinson G, Leung RS. Obstructive sleep
    apnea and incident diabetes: a historical cohort study. Am J Respir Crit Care
    Med. 2014;190:218–225. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/24897551)] [[Google
    Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Obstructive+sleep+apnea+and+incident+diabetes:+a+historical+cohort+study&author=T+Kendzerska&author=AS+Gershon&author=G+Hawker&author=G+Tomlinson&author=RS+Leung&volume=190&publication_year=2014&pages=218-225&pmid=24897551&)]'
  id: totrans-split-261
  prefs: []
  type: TYPE_NORMAL
  zh: Kendzerska T, Gershon AS, Hawker G, Tomlinson G, Leung RS. 阻塞性睡眠呼吸暂停与糖尿病发病的历史队列研究。Am
    J Respir Crit Care Med. 2014;190:218–225. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/24897551)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Obstructive+sleep+apnea+and+incident+diabetes:+a+historical+cohort+study&author=T+Kendzerska&author=AS+Gershon&author=G+Hawker&author=G+Tomlinson&author=RS+Leung&volume=190&publication_year=2014&pages=218-225&pmid=24897551&)]
- en: 10\.
  id: totrans-split-262
  prefs: []
  type: TYPE_NORMAL
  zh: 10\.
- en: Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered
    breathing among middle-aged adults. N Engl J Med. 1993;328:1230–1235. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/8464434)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=The+occurrence+of+sleep-disordered+breathing+among+middle-aged+adults&author=T+Young&author=M+Palta&author=J+Dempsey&author=J+Skatrud&author=S+Weber&volume=328&publication_year=1993&pages=1230-1235&pmid=8464434&)]
  id: totrans-split-263
  prefs: []
  type: TYPE_NORMAL
  zh: Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. 中年成人中睡眠障碍的发生。N Engl
    J Med. 1993;328:1230–1235. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/8464434)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=The+occurrence+of+sleep-disordered+breathing+among+middle-aged+adults&author=T+Young&author=M+Palta&author=J+Dempsey&author=J+Skatrud&author=S+Weber&volume=328&publication_year=1993&pages=1230-1235&pmid=8464434&)]
- en: 11\.
  id: totrans-split-264
  prefs: []
  type: TYPE_NORMAL
  zh: 11\.
- en: 'Quan SF, Howard BV, Iber C, et al. The Sleep Heart Health Study: design, rationale,
    and methods. Sleep. 1997;20:1077–1085. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/9493915)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sleep&title=The+Sleep+Heart+Health+Study:+design,+rationale,+and+methods&author=SF+Quan&author=BV+Howard&author=C+Iber&volume=20&publication_year=1997&pages=1077-1085&pmid=9493915&)]'
  id: totrans-split-265
  prefs: []
  type: TYPE_NORMAL
  zh: Quan SF, Howard BV, Iber C, 等。睡眠心脏健康研究：设计、理念和方法。Sleep。1997;20:1077–1085。[[PubMed](https://pubmed.ncbi.nlm.nih.gov/9493915)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sleep&title=The+Sleep+Heart+Health+Study:+design,+rationale,+and+methods&author=SF+Quan&author=BV+Howard&author=C+Iber&volume=20&publication_year=1997&pages=1077-1085&pmid=9493915&)]
- en: 12\.
  id: totrans-split-266
  prefs: []
  type: TYPE_NORMAL
  zh: 12\.
- en: 'Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing
    in women: effects of gender. Am J Respir Crit Care Med. 2001;163:608–613. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11254512)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Prevalence+of+sleep-disordered+breathing+in+women:+effects+of+gender&author=EO+Bixler&author=AN+Vgontzas&author=HM+Lin&volume=163&publication_year=2001&pages=608-613&pmid=11254512&)]'
  id: totrans-split-267
  prefs: []
  type: TYPE_NORMAL
  zh: Bixler EO, Vgontzas AN, Lin HM, 等。女性睡眠呼吸紊乱的流行率：性别影响。Am J Respir Crit Care Med。2001;163:608–613。[[PubMed](https://pubmed.ncbi.nlm.nih.gov/11254512)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Prevalence+of+sleep-disordered+breathing+in+women:+effects+of+gender&author=EO+Bixler&author=AN+Vgontzas&author=HM+Lin&volume=163&publication_year=2001&pages=608-613&pmid=11254512&)]
- en: 13\.
  id: totrans-split-268
  prefs: []
  type: TYPE_NORMAL
  zh: 13\.
- en: Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence
    of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–1014. [[PMC
    free article](/pmc/articles/PMC3639722/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/23589584)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&title=Increased+prevalence+of+sleep-disordered+breathing+in+adults&author=PE+Peppard&author=T+Young&author=JH+Barnet&author=M+Palta&author=EW+Hagen&volume=177&publication_year=2013&pages=1006-1014&pmid=23589584&)]
  id: totrans-split-269
  prefs: []
  type: TYPE_NORMAL
  zh: Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM。成年人睡眠呼吸紊乱的增加流行率。Am
    J Epidemiol。2013;177:1006–1014。[[PMC免费文章](/pmc/articles/PMC3639722/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/23589584)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&title=Increased+prevalence+of+sleep-disordered+breathing+in+adults&author=PE+Peppard&author=T+Young&author=JH+Barnet&author=M+Palta&author=EW+Hagen&volume=177&publication_year=2013&pages=1006-1014&pmid=23589584&)]
- en: 14\.
  id: totrans-split-270
  prefs: []
  type: TYPE_NORMAL
  zh: 14\.
- en: Ip MS, Lam B, Lauder IJ, et al. A community study of sleep-disordered breathing
    in middle-aged Chinese men in Hong Kong. Chest. 2001;119:62–69. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11157585)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Chest&title=A+community+study+of+sleep-disordered+breathing+in+middle-aged+Chinese+men+in+Hong+Kong&author=MS+Ip&author=B+Lam&author=IJ+Lauder&volume=119&publication_year=2001&pages=62-69&pmid=11157585&)]
  id: totrans-split-271
  prefs: []
  type: TYPE_NORMAL
  zh: Ip MS, Lam B, Lauder IJ, 等。香港中年华裔男性的睡眠呼吸紊乱社区研究。Chest。2001;119:62–69。[[PubMed](https://pubmed.ncbi.nlm.nih.gov/11157585)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Chest&title=A+community+study+of+sleep-disordered+breathing+in+middle-aged+Chinese+men+in+Hong+Kong&author=MS+Ip&author=B+Lam&author=IJ+Lauder&volume=119&publication_year=2001&pages=62-69&pmid=11157585&)]
- en: 15\.
  id: totrans-split-272
  prefs: []
  type: TYPE_NORMAL
  zh: 15\.
- en: 'Redline S, Sotres-Alvarez D, Loredo J, et al. Sleep-disordered breathing in
    Hispanic/Latino individuals of diverse backgrounds: the Hispanic Community Health
    Study/Study of Latinos. Am J Respir Crit Care Med. 2014;189:335–344. [[PMC free
    article](/pmc/articles/PMC3977733/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/24392863)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Sleep-disordered+breathing+in+Hispanic/Latino+individuals+of+diverse+backgrounds:+the+Hispanic+Community+Health+Study/Study+of+Latinos&author=S+Redline&author=D+Sotres-Alvarez&author=J+Loredo&volume=189&publication_year=2014&pages=335-344&pmid=24392863&)]'
  id: totrans-split-273
  prefs: []
  type: TYPE_NORMAL
  zh: Redline S, Sotres-Alvarez D, Loredo J, 等。西班牙裔/拉丁裔社区健康研究/拉丁裔研究中的睡眠呼吸紊乱。Am J Respir
    Crit Care Med。2014;189:335–344。[[PMC免费文章](/pmc/articles/PMC3977733/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/24392863)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Sleep-disordered+breathing+in+Hispanic/Latino+individuals+of+diverse+backgrounds:+the+Hispanic+Community+Health+Study/Study+of+Latinos&author=S+Redline&author=D+Sotres-Alvarez&author=J+Loredo&volume=189&publication_year=2014&pages=335-344&pmid=24392863&)]
- en: 16\.
  id: totrans-split-274
  prefs: []
  type: TYPE_NORMAL
  zh: 16\.
- en: 'Bearpark H, Elliott L, Grunstein R, et al. Snoring and sleep apnea: a population
    study in Australian men. Am J Respir Crit Care Med. 1995;151:1459–1465. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/7735600)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Snoring+and+sleep+apnea:+a+population+study+in+Australian+men&author=H+Bearpark&author=L+Elliott&author=R+Grunstein&volume=151&publication_year=1995&pages=1459-1465&pmid=7735600&)]'
  id: totrans-split-275
  prefs: []
  type: TYPE_NORMAL
  zh: Bearpark H, Elliott L, Grunstein R, 等。澳大利亚男性鼾声和睡眠呼吸暂停的人群研究。Am J Respir Crit
    Care Med。1995;151:1459–1465。[[PubMed](https://pubmed.ncbi.nlm.nih.gov/7735600)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Snoring+and+sleep+apnea:+a+population+study+in+Australian+men&author=H+Bearpark&author=L+Elliott&author=R+Grunstein&volume=151&publication_year=1995&pages=1459-1465&pmid=7735600&)]
- en: 17\.
  id: totrans-split-276
  prefs: []
  type: TYPE_NORMAL
  zh: '17\. '
- en: Tufi kS, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea
    syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med. 2010;11:441–446.
    [[PubMed](https://pubmed.ncbi.nlm.nih.gov/20362502)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sleep+Med&title=Obstructive+sleep+apnea+syndrome+in+the+Sao+Paulo+Epidemiologic+Sleep+Study&author=kS+Tufi&author=R+Santos-Silva&author=JA+Taddei&author=LR+Bittencourt&volume=11&publication_year=2010&pages=441-446&pmid=20362502&)]
  id: totrans-split-277
  prefs: []
  type: TYPE_NORMAL
  zh: Tufi kS, Santos-Silva R, Taddei JA, Bittencourt LR。圣保罗流行性睡眠研究中的阻塞性睡眠呼吸暂停综合征。Sleep
    Med。2010;11:441–446。[[PubMed](https://pubmed.ncbi.nlm.nih.gov/20362502)] [[Google
    Scholar](https://scholar.google.com/scholar_lookup?journal=Sleep+Med&title=Obstructive+sleep+apnea+syndrome+in+the+Sao+Paulo+Epidemiologic+Sleep+Study&author=kS+Tufi&author=R+Santos-Silva&author=JA+Taddei&author=LR+Bittencourt&volume=11&publication_year=2010&pages=441-446&pmid=20362502&)]
- en: 18\.
  id: totrans-split-278
  prefs: []
  type: TYPE_NORMAL
  zh: '18\. '
- en: Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and
    related clinical features in a population-based sample of subjects aged 30 to
    70 yr. Am J Respir Crit Care Med. 2001;163:685–689. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11254524)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Obstructive+sleep+apnea-hypopnea+and+related+clinical+features+in+a+population-based+sample+of+subjects+aged+30+to+70+yr&author=J+Duran&author=S+Esnaola&author=R+Rubio&author=A+Iztueta&volume=163&publication_year=2001&pages=685-689&pmid=11254524&)]
  id: totrans-split-279
  prefs: []
  type: TYPE_NORMAL
  zh: Duran J, Esnaola S, Rubio R, Iztueta A。30至70岁受试者中阻塞性睡眠呼吸暂停-低通气及相关临床特征的人群样本。Am
    J Respir Crit Care Med。2001;163:685–689。[[PubMed](https://pubmed.ncbi.nlm.nih.gov/11254524)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Obstructive+sleep+apnea-hypopnea+and+related+clinical+features+in+a+population-based+sample+of+subjects+aged+30+to+70+yr&author=J+Duran&author=S+Esnaola&author=R+Rubio&author=A+Iztueta&volume=163&publication_year=2001&pages=685-689&pmid=11254524&)]
- en: 19\.
  id: totrans-split-280
  prefs: []
  type: TYPE_NORMAL
  zh: '19\. '
- en: 'Iber C, Ancoli-Israel S, Chesson AL, Qaun SF. The AASM manual for the scoring
    of sleep and associated events: rules, terminology and technical specifications.
    1st edn. Westchester: American Academy of Sleep Medicine; 2007\. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=The+AASM+manual+for+the+scoring+of+sleep+and+associated+events:+rules,+terminology+and+technical+specifications&author=C+Iber&author=S+Ancoli-Israel&author=AL+Chesson&author=SF+Qaun&publication_year=2007&)]'
  id: totrans-split-281
  prefs: []
  type: TYPE_NORMAL
  zh: Iber C, Ancoli-Israel S, Chesson AL, Qaun SF。AASM睡眠及相关事件评分手册：规则、术语及技术规范。第1版。Westchester：美国睡眠医学会；2007年。[[Google
    Scholar](https://scholar.google.com/scholar_lookup?title=The+AASM+manual+for+the+scoring+of+sleep+and+associated+events:+rules,+terminology+and+technical+specifications&author=C+Iber&author=S+Ancoli-Israel&author=AL+Chesson&author=SF+Qaun&publication_year=2007&)]
- en: 20\.
  id: totrans-split-282
  prefs: []
  type: TYPE_NORMAL
  zh: '20\. '
- en: 'American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders
    in adults: recommendations for syndrome definition and measurement techniques
    in clinical research. Sleep. 1999;22:667–689. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10450601)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sleep&title=Sleep-related+breathing+disorders+in+adults:+recommendations+for+syndrome+definition+and+measurement+techniques+in+clinical+research&volume=22&publication_year=1999&pages=667-689&pmid=10450601&)]'
  id: totrans-split-283
  prefs: []
  type: TYPE_NORMAL
  zh: 美国睡眠医学会工作组。成人睡眠相关呼吸障碍：临床研究中综合征定义和测量技术的建议。Sleep。1999;22:667–689。[[PubMed](https://pubmed.ncbi.nlm.nih.gov/10450601)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sleep&title=Sleep-related+breathing+disorders+in+adults:+recommendations+for+syndrome+definition+and+measurement+techniques+in+clinical+research&volume=22&publication_year=1999&pages=667-689&pmid=10450601&)]
- en: 21\.
  id: totrans-split-284
  prefs: []
  type: TYPE_NORMAL
  zh: '21\. '
- en: 'Berry RB, Budhiraja R, Gottlieb DJ, et al. for the American Academy of Sleep
    Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM
    Manual for the Scoring of Sleep and Associated Events—deliberations of the Sleep
    Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin
    Sleep Med. 2012;8:597–619. [[PMC free article](/pmc/articles/PMC3459210/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/23066376)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Clin+Sleep+Med&title=Rules+for+scoring+respiratory+events+in+sleep:+update+of+the+2007+AASM+Manual+for+the+Scoring+of+Sleep+and+Associated+Events%E2%80%94deliberations+of+the+Sleep+Apnea+Definitions+Task+Force+of+the+American+Academy+of+Sleep+Medicine&author=RB+Berry&author=R+Budhiraja&author=DJ+Gottlieb&volume=8&publication_year=2012&pages=597-619&pmid=23066376&)]'
  id: totrans-split-285
  prefs: []
  type: TYPE_NORMAL
- en: 22\.
  id: totrans-split-286
  prefs: []
  type: TYPE_NORMAL
- en: 'Firmann M, Mayor V, Vidal PM, et al. The CoLaus study: a population-based study
    to investigate the epidemiology and genetic determinants of cardiovascular risk
    factors and metabolic syndrome. BMC Cardiovasc Disord. 2008;8:6. [[PMC free article](/pmc/articles/PMC2311269/)]
    [[PubMed](https://pubmed.ncbi.nlm.nih.gov/18366642)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMC+Cardiovasc+Disord&title=The+CoLaus+study:+a+population-based+study+to+investigate+the+epidemiology+and+genetic+determinants+of+cardiovascular+risk+factors+and+metabolic+syndrome&author=M+Firmann&author=V+Mayor&author=PM+Vidal&volume=8&publication_year=2008&pages=6&pmid=18366642&)]'
  id: totrans-split-287
  prefs: []
  type: TYPE_NORMAL
- en: 23\.
  id: totrans-split-288
  prefs: []
  type: TYPE_NORMAL
- en: 'Preisig M, Waeber G, Vollenweider P, et al. The PsyCoLaus study: methodology
    and characteristics of the sample of a population-based survey on psychiatric
    disorders and their association with genetic and cardiovascular risk factors.
    BMC Psychiatry. 2009;9:9. [[PMC free article](/pmc/articles/PMC2667506/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/19292899)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMC+Psychiatry&title=The+PsyCoLaus+study:+methodology+and+characteristics+of+the+sample+of+a+population-based+survey+on+psychiatric+disorders+and+their+association+with+genetic+and+cardiovascular+risk+factors&author=M+Preisig&author=G+Waeber&author=P+Vollenweider&volume=9&publication_year=2009&pages=9&pmid=19292899&)]'
  id: totrans-split-289
  prefs: []
  type: TYPE_NORMAL
- en: 25\.
  id: totrans-split-290
  prefs: []
  type: TYPE_NORMAL
- en: Redline S, Sanders MH, Lind BK, et al. for the Sleep Heart Health Research Group
    . Methods for obtaining and analyzing unattended polysomnography data for a multicenter
    study. Sleep. 1998;21:759–767. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11300121)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sleep&title=.+Methods+for+obtaining+and+analyzing+unattended+polysomnography+data+for+a+multicenter+study&author=S+Redline&author=MH+Sanders&author=BK+Lind&volume=21&publication_year=1998&pages=759-767&pmid=11300121&)]
  id: totrans-split-291
  prefs: []
  type: TYPE_NORMAL
- en: 26\.
  id: totrans-split-292
  prefs: []
  type: TYPE_NORMAL
- en: 'National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,
    and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
    on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult
    Treatment Panel III): final report. Circulation. 2002;106:3143–31421. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/12485966)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Circulation&title=Third+Report+of+the+National+Cholesterol+Education+Program+(NCEP)+Expert+Panel+on+Detection,+Evaluation,+and+Treatment+of+High+Blood+Cholesterol+in+Adults+(Adult+Treatment+Panel+III):+final+report&volume=106&publication_year=2002&pages=3143-31421&pmid=12485966&)]'
  id: totrans-split-293
  prefs: []
  type: TYPE_NORMAL
- en: 27\.
  id: totrans-split-294
  prefs: []
  type: TYPE_NORMAL
- en: Ballester E, Badia JR, Hernandez L, Farre R, Navajas D, Montserrat JM. Nasal
    prongs in the detection of sleep-related disordered breathing in the sleep apnoea/hypopnoea
    syndrome. Eur Respir J. 1998;11:880–883. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/9623691)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&title=Nasal+prongs+in+the+detection+of+sleep-related+disordered+breathing+in+the+sleep+apnoea/hypopnoea+syndrome&author=E+Ballester&author=JR+Badia&author=L+Hernandez&author=R+Farre&author=D+Navajas&volume=11&publication_year=1998&pages=880-883&pmid=9623691&)]
  id: totrans-split-295
  prefs: []
  type: TYPE_NORMAL
- en: 28\.
  id: totrans-split-296
  prefs: []
  type: TYPE_NORMAL
- en: Thurnheer R, Xie X, Bloch KE. Accuracy of nasal cannula pressure recordings
    for assessment of ventilation during sleep. Am J Respir Crit Care Med. 2001;164:1914–1919.
    [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11734446)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Accuracy+of+nasal+cannula+pressure+recordings+for+assessment+of+ventilation+during+sleep&author=R+Thurnheer&author=X+Xie&author=KE+Bloch&volume=164&publication_year=2001&pages=1914-1919&pmid=11734446&)]
  id: totrans-split-297
  prefs: []
  type: TYPE_NORMAL
- en: 29\.
  id: totrans-split-298
  prefs: []
  type: TYPE_NORMAL
- en: 'Tishler PV, Larkin EK, Schluchter MD, Redline S. Incidence of sleep-disordered
    breathing in an urban adult population: the relative importance of risk factors
    in the development of sleep-disordered breathing. JAMA. 2003;289:2230–2237. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/12734134)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA&title=Incidence+of+sleep-disordered+breathing+in+an+urban+adult+population:+the+relative+importance+of+risk+factors+in+the+development+of+sleep-disordered+breathing&author=PV+Tishler&author=EK+Larkin&author=MD+Schluchter&author=S+Redline&volume=289&publication_year=2003&pages=2230-2237&pmid=12734134&)]'
  id: totrans-split-299
  prefs: []
  type: TYPE_NORMAL
- en: 30\.
  id: totrans-split-300
  prefs: []
  type: TYPE_NORMAL
- en: 'Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al. Effect of continuous
    positive airway pressure on the incidence of hypertension and cardiovascular events
    in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial.
    JAMA. 2012;307:2161–2168. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/22618923)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA&title=Effect+of+continuous+positive+airway+pressure+on+the+incidence+of+hypertension+and+cardiovascular+events+in+nonsleepy+patients+with+obstructive+sleep+apnea:+a+randomized+controlled+trial&author=F+Barbe&author=J+Duran-Cantolla&author=M+Sanchez-de-la-Torre&volume=307&publication_year=2012&pages=2161-2168&pmid=22618923&)]'
  id: totrans-split-301
  prefs: []
  type: TYPE_NORMAL
- en: 32\.
  id: totrans-split-302
  prefs: []
  type: TYPE_NORMAL
- en: 'Aurora RN, Punjabi NM. Obstructive sleep apnoea and type 2 diabetes mellitus:
    a bidirectional association. Lancet Respir Med. 2013;1:329–338. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/24429158)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet+Respir+Med&title=Obstructive+sleep+apnoea+and+type+2+diabetes+mellitus:+a+bidirectional+association&author=RN+Aurora&author=NM+Punjabi&volume=1&publication_year=2013&pages=329-338&pmid=24429158&)]'
  id: totrans-split-303
  prefs: []
  type: TYPE_NORMAL
- en: 33\.
  id: totrans-split-304
  prefs: []
  type: TYPE_NORMAL
- en: 'Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and
    type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005;172:1590–1595.
    [[PMC free article](/pmc/articles/PMC2718458/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16192452)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Association+of+sleep+apnea+and+type+II+diabetes:+a+population-based+study&author=KJ+Reichmuth&author=D+Austin&author=JB+Skatrud&author=T+Young&volume=172&publication_year=2005&pages=1590-1595&pmid=16192452&)]'
  id: totrans-split-305
  prefs: []
  type: TYPE_NORMAL
- en: 34\.
  id: totrans-split-306
  prefs: []
  type: TYPE_NORMAL
- en: Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep
    apnoea is independently associated with an increased prevalence of metabolic syndrome.
    Eur Heart J. 2004;25:735–741. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/15120883)]
    [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Eur+Heart+J&title=Obstructive+sleep+apnoea+is+independently+associated+with+an+increased+prevalence+of+metabolic+syndrome&author=SR+Coughlin&author=L+Mawdsley&author=JA+Mugarza&author=PM+Calverley&author=JP+Wilding&volume=25&publication_year=2004&pages=735-741&pmid=15120883&)]
  id: totrans-split-307
  prefs: []
  type: TYPE_NORMAL
